NN (NNBR) 10-K 10 Mar 23 2022 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Feb. 28, 2023	Jun. 30, 2022
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	001-39268
Entity Registrant Name	NN, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	62-1096725
Entity Address, Address Line One	6210 Ardrey Kell Road, Suite 600
Entity Address, City or Town	Charlotte
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28277
City Area Code	980
Local Phone Number	264-4300
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	NNBR
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 67.5
Entity Common Stock, Shares Outstanding		43,846,073
Documents Incorporated by Reference	Portions of the Proxy Statement with respect to the 2023 Annual Meeting of Stockholders are incorporated by reference in Part III, Items 10 to 14 of this Annual Report on Form 10-K as indicated herein. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2022.
Entity Central Index Key	0000918541
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Document Information [Line Items]
Auditor Name	GRANT THORNTON LLP
Auditor Location	Charlotte, North Carolina
Auditor Firm ID	248

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 498,738	$ 477,584	$ 427,534
Cost of sales (exclusive of depreciation and amortization shown separately below)	421,105	389,995	343,594
Selling, general, and administrative expense	49,635	51,489	58,055
Depreciation and amortization	47,231	46,195	45,680
Goodwill impairment of continuing operations	0	0	92,942
Other operating expense (income), net	1,859	(1,091)	4,720
Loss from operations	(21,092)	(9,004)	(117,457)
Interest expense	15,041	12,664	18,898
Loss on extinguishment of debt and write-off of debt issuance costs	0	2,390	144
Derivative payments on interest rate swap	0	1,717	4,133
Loss on interest rate swap	0	2,033	11,669
Other expense (income), net	(5,064)	(5,366)	(213)
Loss from continuing operations before benefit (provision) for income taxes and share of net income from joint venture	(31,069)	(22,442)	(152,088)
Benefit (provision) for income taxes	(1,621)	1,756	8,972
Share of net income from joint venture	6,592	6,261	3,626
Loss from continuing operations	(26,098)	(14,425)	(139,490)
Income from discontinued operations, net of tax (Note 2)	0	1,200	38,898
Net loss	(26,098)	(13,225)	(100,592)
Other comprehensive income (loss):
Foreign currency translation loss	(8,156)	(1,135)	(1,683)
Reclassification adjustment for discontinued operations	0	0	(5,961)
Change in fair value, net of tax	3,358	59	(12,443)
Reclassification adjustment for (gains) losses included in net loss, net of tax	420	(2,906)	(18,987)
Other comprehensive income (loss)	(5,218)	1,830	10,822
Comprehensive loss	$ (31,316)	$ (11,395)	$ (89,770)
Basic net loss per common share:
Loss from continuing operations per common share (in usd per share)	$ (0.83)	$ (0.82)	$ (3.60)
Income (loss) from discontinued operations per common share (in usd per share)	0	0.03	0.92
Net loss per common share (in usd per share)	$ (0.83)	$ (0.79)	$ (2.68)
Weighted average common shares outstanding (in shares)	44,680	44,011	42,199
Diluted net loss per common share:
Diluted loss from continuing operations per common share (in usd per share)	$ (0.83)	$ (0.82)	$ (3.60)
Income (loss) from discontinued operations per common share (in usd per share)	0	0.03	0.92
Net loss per common share (in usd per share)	$ (0.83)	$ (0.79)	$ (2.68)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets, Current [Abstract]
Cash and cash equivalents	$ 12,808	$ 28,656
Accounts receivable, net of allowances of $1,469 and $1,352 at December 31, 2022 and 2021, respectively	74,129	71,419
Inventories	80,682	75,027
Income tax receivable	12,164	11,808
Prepaid assets	2,794	2,172
Other current assets	9,123	7,200
Total current assets	191,700	196,282
Property, plant and equipment, net	197,637	209,105
Operating lease right-of-use assets	46,713	46,443
Intangible assets, net	72,891	88,718
Investment in joint venture	31,802	34,045
Deferred tax assets	102	314
Other non-current assets	5,282	4,194
Total assets	546,127	579,101
Liabilities, Current [Abstract]
Accounts payable	45,871	36,710
Accrued salaries, wages and benefits	11,671	17,739
Income tax payable	926	2,072
Current maturities of long-term debt	3,321	3,074
Current portion of operating lease liabilities	5,294	5,704
Other current liabilities	11,723	8,718
Total current liabilities	78,806	74,017
Deferred tax liabilities	5,596	7,456
Long-term debt, net of current portion	149,389	151,052
Operating lease liabilities, net of current portion	51,411	51,295
Other non-current liabilities	9,960	17,289
Total liabilities	295,162	301,109
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock - $0.01 par value per share, 90,000 shares authorized, 43,856 and 43,027 shares issued and outstanding at December 31, 2022 and 2021, respectively	439	430
Additional paid-in capital	468,143	474,757
Accumulated deficit	(245,198)	(219,100)
Accumulated other comprehensive loss	(37,120)	(31,902)
Total stockholders’ equity	186,264	224,185
Total liabilities, preferred stock, and stockholders’ equity	546,127	579,101
Series D Preferred Stock
Liabilities, Current [Abstract]
Series D perpetual preferred stock - $0.01 par value per share, 65 shares authorized, issued and outstanding at December 31, 2022 and 2021, respectively	64,701	53,807
Series D perpetual preferred stock - $0.01 par value per share, 65 shares authorized, issued and outstanding at December 31, 2022 and 2021, respectively	$ 64,701	$ 53,807

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current	$ 1,469	$ 1,352
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	90,000	90,000
Common stock issued (in shares)	43,856	43,027
Common stock outstanding (in shares)	43,856	43,027
Series D Preferred Stock
Statement of Financial Position [Abstract]
Preferred stock, par value (in usd per share)	$ 0.01	$ 0.01
Preferred stock authorized (in shares)	65	65
Preferred stock issued (in shares)	65	65
Preferred stock outstanding (in shares)	65	65
Preferred stock, par value (in usd per share)	$ 0.01	$ 0.01
Preferred stock authorized (in shares)	65	65
Preferred stock issued (in shares)	65	65
Preferred stock outstanding (in shares)	65	65

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional paid-in capital	Warrants	Accumulated deficit	Accumulated other comprehensive income (loss)
Beginning Balance, (in shares) at Dec. 31, 2019	42,313
Beginning Balance at Dec. 31, 2019	$ 353,277	$ 423	$ 501,615	$ 1,076	$ (105,283)	$ (44,554)
Net Income (Loss)	(100,592)				(100,592)
Dividends accrued for preferred stock	$ (12,373)		(12,373)
Shares issued under stock incentive plans, net of forfeitures	417
Shares issued under stock incentive plans, net of forfeitures	$ 0	(4)	(4)
Share-based compensation expense	$ 4,251		4,251
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation	44
Restricted shares forgiven for taxes	$ (157)	0	(157)
Reclassification of warrants to liabilities	(1,076)			(1,076)
Other comprehensive income (loss)	10,822					10,822
Ending Balance at Dec. 31, 2020	$ 254,152	427	493,332	0	(205,875)	(33,732)
Ending Balance, (in shares) at Dec. 31, 2020	42,686
Net Income (Loss)	$ (13,225)				(13,225)
Dividends accrued for preferred stock	$ (21,478)		(21,478)
Shares issued under stock incentive plans, net of forfeitures	387
Shares issued under stock incentive plans, net of forfeitures	$ 0	(4)	(4)
Share-based compensation expense	$ 3,221		3,221
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation	52
Restricted shares forgiven for taxes	$ (363)	(1)	(362)
Shares issued for option exercises (in shares)	6
Shares issued for option exercises	$ 48	0	48
Other comprehensive income (loss)	1,830					1,830
Ending Balance at Dec. 31, 2021	$ 224,185	430	474,757	0	(219,100)	(31,902)
Ending Balance, (in shares) at Dec. 31, 2021	43,027
Net Income (Loss)	$ (26,098)				(26,098)
Dividends accrued for preferred stock	$ (10,894)		(10,894)
Shares issued under stock incentive plans, net of forfeitures	860
Shares issued under stock incentive plans, net of forfeitures	$ 0	(9)	(9)
Share-based compensation expense	$ 4,377		4,377
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation	31
Restricted shares forgiven for taxes	$ (88)	0	(88)
Other comprehensive income (loss)	(5,218)					(5,218)
Ending Balance at Dec. 31, 2022	$ 186,264	$ 439	$ 468,143	$ 0	$ (245,198)	$ (37,120)
Ending Balance, (in shares) at Dec. 31, 2022	43,856

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net Income (Loss)		$ (26,098)	$ (13,225)		$ (100,592)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Depreciation and amortization of continuing operations		47,231	46,195		45,680
Depreciation and amortization of discontinued operations		0	0		35,731
Amortization of debt issuance costs and discount		1,361	1,381		15,692
Goodwill impairment of continuing operations		0	0		92,942
Goodwill impairment of discontinued operations		0	0		146,757
Impairments of property, plant and equipment		0	0		4,148
Loss on extinguishment of debt and write-off of debt issuance costs		0	2,390		1,532
Total derivative loss (gain), net of cash settlements		(5,265)	(3,259)		15,309
Share of net income from joint venture, net of cash dividends received		(347)	(6,261)		(3,626)
Gain on disposal of discontinued operations, net of tax and cost to sell		0	(1,200)		(233,824)
Share-based compensation expense		4,377	3,216		4,226
Deferred income taxes		(1,814)	(4,845)		(21,697)
Other		(3,207)	(2,611)		(4,730)
Changes in operating assets and liabilities:
Accounts receivable		(4,920)	13,698		10,831
Inventories		(6,672)	(12,959)		5,114
Accounts payable		8,619	343		(8,606)
Income taxes receivable and payable, net		(1,457)	(4,516)		(633)
Other		(4,091)	(2,761)		11,295
Net cash provided by operating activities		7,717	15,586		15,549
Net Cash Provided by (Used in) Investing Activities [Abstract]
Acquisition of property, plant and equipment		(17,952)	(18,221)		(23,773)
Proceeds from (cash paid for post-closing adjustments on) sale of business, net of cash sold		0	(3,880)		743,178
Proceeds from sale of property, plant, and equipment		460	1,418		3,317
Cash settlements of interest rate swap		0	(15,420)		(4,133)
Other		0	0		695
Net cash provided by (used in) investing activities		(17,492)	(36,103)		719,284
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash paid for debt issuance costs		(136)	(7,360)		(661)
Proceeds from issuance of preferred stock		0	61,793		0
Redemption of preferred stock		0	(122,434)		0
Proceeds from long-term debt		46,000	171,000		66,195
Repayments of long-term debt		(47,958)	(93,729)		(776,331)
Repayments of short-term debt, net		0	(1,563)		(924)
Other		(3,092)	(5,150)		(3,133)
Net cash provided by (used in) financing activities		(5,186)	2,557		(714,854)
Effect of exchange rate changes on cash flows		(887)	(1,522)		(3,544)
Net change in cash and cash equivalents		(15,848)	(19,482)		16,435
Cash and cash equivalents at beginning of year	[1]	28,656	48,138		31,703
Cash and cash equivalents at end of year		12,808	28,656	[1]	48,138	[1]
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Non-cash additions to property, plant and equipment		1,266	4,438		9,644
Supplemental Cash Flow Information [Abstract]
Cash paid for interest		13,344	10,739		51,542
Cash paid for income taxes		$ 4,739	$ 7,624		$ 2,241
[1]Cash and cash equivalents include $13.8 million of cash and cash equivalents that were included in current assets of discontinued operations as of December 31, 2019.

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical) $ in Millions	Dec. 31, 2019 USD ($)
Statement of Cash Flows [Abstract]
Cash and Cash Equivalents, Disposal Group	$ 13.8

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Nature of Business NN, Inc. is a diversified industrial company that combines in-depth materials science expertise with advanced engineering and production capabilities to design and manufacture high-precision metal and plastic components and assemblies for a variety of end markets on a global basis. As used in this Annual Report on Form 10-K (this “Annual Report”), the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries. We have 31 facilities in North America, Europe, South America, and Asia. Basis of Presentation The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Certain prior period amounts have been reclassified to conform to the current year’s presentation. Except for per share data or as otherwise indicated, all U.S. dollar amounts presented in the tables in these Notes to Consolidated Financial Statements are in thousands. Principles of Consolidation Our consolidated financial statements include the accounts of NN, Inc., and its wholly owned subsidiaries. We own a 49% interest in a joint venture which we account for using the equity method (see Note 9). All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates in the Preparation of Consolidated Financial Statements The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to use estimates and assumptions that affect the reported amounts of certain assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates. Accounting Standards Recently Adopted In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, ASU 2020-06 simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. In addition, ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. Further, for the diluted earnings-per-share calculation, the new guidance requires entities to use the if-converted method for all convertible instruments and generally requires entities to include the effect of share settlement for instruments that may be settled in cash or shares, among other things. The adoption of ASU 2020-06 effective January 1, 2022 did not have a material impact on our consolidated financial statements and related disclosures. In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU 2021-04”), which clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. Specifically, ASU 2021-04 requires the issuer to treat a modification of an equity-classified warrant as an exchange of the original warrant. The difference between the fair value of the modified warrant and the fair value of the warrant immediately before modification is then recognized as an issuance cost or discount of the related transaction. Since we do not have any equity-classified written call options that would be subject to this guidance, the adoption of ASU 2021-04 did not have any impact on our consolidated financial statements and related disclosures during the year ended December 31, 2022. In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance (“ASU 2021-10”), which requires business entities to provide certain annual disclosures when they have received government assistance and use a grant or contribution accounting model by analogy to other accounting guidance. We have adopted ASU 2021-10 prospectively for the year ended December 31, 2022. Cash and Cash Equivalents Cash and cash equivalents include cash and highly liquid investments with original maturities of three months or less. We maintain cash balances in transaction accounts with various financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). Although we maintain balances that exceed the federally insured limit, we have not experienced any losses related to these balances, and we believe credit risk to be minimal. We had $12.5 million and $17.6 million in cash and cash equivalents as of December 31, 2022 and 2021, respectively, held at foreign financial institutions. Fair Value Measurements Fair value principles prioritize valuation inputs across three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the assumptions used to measure assets and liabilities at fair value. An asset or liability’s classification within the various levels is determined based on the lowest level input that is significant to the fair value measurement. Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are recorded at their net realizable value. We maintain allowances for estimated losses resulting from the inability of our customers to make required payments. The allowances are based on the amount that we ultimately expect to collect from our customers. We evaluate the collectability of accounts receivable based on a combination of factors including number of days receivables are past due, historical collection experience, current market conditions, and forecasted direction of economic and business environment. Accounts receivable are written off at the time a customer receivable is deemed uncollectible. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using standard costs, which approximates the average cost method. Our policy is to expense abnormal amounts of idle facility expense, freight, handling cost, and waste included in cost of products sold. In addition, we allocate fixed production overheads based on the normal production capacity of our facilities. Inventory valuations were developed using normalized production capacities for each of our manufacturing locations. The costs from excess capacity or under-utilization of fixed production overheads were expensed in the period incurred and are not included as a component of inventory. Inventories also include tools, molds, and dies in progress that we are producing and will ultimately sell to our customers. These inventories are also carried at the lower of cost or net realizable value. Property, Plant and Equipment Property, plant and equipment are stated at cost less accumulated depreciation. Assets to be disposed of are stated at the lower of depreciated cost or fair market value less estimated selling costs. Expenditures for maintenance and repairs are charged to expense as incurred. Major renewals and improvements are capitalized. When a property item is retired, its cost and related accumulated depreciation are removed from the property accounts and any gain or loss is recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss). We review the carrying values of long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Property, plant and equipment also includes tools, molds, and dies used in manufacturing. Depreciation is calculated based on historical cost using the straight-line method over the estimated useful lives of the depreciable assets. Estimated useful lives for buildings and land improvements generally range from 10 to 40 years. Estimated useful lives for machinery and equipment generally range from 3 to 12 years. Estimated useful lives for leasehold improvements are based on the life of the lease. Leases We determine whether an arrangement is a lease at inception. Lease right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. When the implicit rate is not readily determinable, we use the estimated incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Amortization of lease ROU assets is recognized in expense on a straight-line basis over the lease term. We recognize short-term leases, which have a term of twelve months or less, on a straight-line basis and do not record a related lease asset or liability for such leases. Finance lease ROU assets consist primarily of equipment used in the manufacturing process with terms of four years to eight years. Operating lease ROU assets consist of the following: • Equipment used in the manufacturing process as well as office equipment with terms of two years to five years; and • Manufacturing plants and office facilities with terms of four years to 20 years. Impairment of Long-Lived Assets Long-lived tangible and intangible assets subject to depreciation or amortization are tested for recoverability when changes in circumstances indicate the carrying value of these assets, or asset groups, may not be recoverable. A test for recoverability is also performed when management has committed to a plan to dispose of a reporting unit or asset group. Assets to be held and used are tested for recoverability when indications of impairment are evident. Recoverability of a long-lived tangible or intangible asset, or asset group, is evaluated by comparing its carrying value to the future estimated undiscounted cash flows expected to be generated by the asset or asset group. If the asset is deemed not recoverable, then the asset is considered impaired and adjusted to fair value which is then depreciated or amortized over its remaining useful life. Assets to be disposed of are recorded at the lesser of carrying value or fair value less costs of disposal. Equity Method Investments Our equity method investment is subject to a review for impairment if, and when, circumstances indicate that a decline in value below its carrying amount may have occurred. Examples of such circumstances include, but are not limited to, a significant deterioration in the earnings performance or business prospects of the investee; a significant adverse change in the regulatory, economic or technological environment of the investee; a significant adverse change in the general market condition of either the geographic area or the industry in which the investee operates; and recurring negative cash flows from operations. If management considers the decline to be other than temporary, we would write down the investment to its estimated fair market value. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Provision has been made for income taxes on unremitted earnings of certain foreign subsidiaries as these earnings are not deemed to be permanently reinvested. We recognize income tax positions that meet the more likely than not threshold and accrue interest and potential penalties related to unrecognized income tax positions which are recorded as a component of the provision (benefit) for income taxes. We treat global intangible low-taxed income (“GILTI”) as a periodic charge in the year in which it arises and therefore do not record deferred taxes for basis differences associated with GILTI. We eliminate disproportionate tax effects from accumulated other comprehensive income (loss) when the circumstances upon which they are premised cease to exist. Revenue Recognition We generally transfer control and recognize revenue when we ship the product from our manufacturing facility to our customer at a point in time, as this is when our customer obtains the ability to direct use of, and obtain substantially all of the remaining benefits from, the product. In limited circumstances, we recognize revenue over time as services are rendered. We have elected to recognize the cost for freight and shipping when control over products has transferred to the customer as a component of cost of sales. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost-plus-margin approach when an observable price is not available. The expected duration of our contracts is one year or less, and we have elected to apply the practical expedient that allows entities to disregard the effects of financing when the contract length is less than one year. The amount of consideration we receive and the revenue we recognize varies with volume rebates and incentives we offer to our customers. We estimate the amount of variable consideration that should be included in the transaction price utilizing the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. We utilize the portfolio approach practical expedient to evaluate sales-related discounts on a portfolio basis to contracts with similar characteristics. The effect on our consolidated financial statements of applying the portfolio approach would not differ materially from evaluation of individual contracts. We give our customers the right to return only defective products in exchange for functioning products or rework of the product. These transactions are evaluated and accounted for under ASC Topic 460, Guarantees , and we estimate the impact to the transaction price based on an analysis of historical experience. Share Based Compensation The cost of stock options, restricted stock, and performance share units is recognized as compensation expense over the vesting periods based on the grant date fair value, net of expected forfeitures. We determine grant date fair value using the Black Scholes financial pricing model for stock options and a Monte Carlo simulation for performance share units that include a market condition for vesting because these awards are not traded in open markets. We determine grant date fair value using the closing price of our common stock on the date of grant for restricted stock and performance share units that include performance conditions for vesting. Common Stock and Preferred Stock Dividends Dividends are recorded as a reduction to retained earnings. When we have an accumulated deficit, dividends are recorded as a reduction of additional paid-in capital. Foreign Currency Translation Assets and liabilities of our foreign subsidiaries are translated at current exchange rates. Revenue, costs, and expenses are translated at average rates prevailing during each reporting period. Translation adjustments arising from the translation of foreign subsidiary financial statements are reported as a component of other comprehensive income (loss) and accumulated other comprehensive income (loss) within stockholders’ equity. Transactions denominated in foreign currencies, including intercompany transactions, are initially recorded at the current exchange rate at the date of the transaction. The balances are adjusted to the current exchange rate as of each balance sheet date and as of the date when the transaction is consummated. Transaction gains or losses, excluding intercompany loan transactions, are expensed as incurred in either cost of sales or selling, general and administrative expense in the Consolidated Statements of Operations and Comprehensive Income (Loss) and were immaterial to the years ended December 31, 2022, 2021, and 2020. Transaction gains or losses on intercompany loan transactions are recognized as incurred in the “Other expense (income), net” line in the Consolidated Statements of Operations and Comprehensive Income (Loss). For the years ended December 31, 2022, 2021, and 2020, transaction gains (losses) on intercompany loan transactions were $0.2 million, $(0.5) million, and $(0.8) million, respectively. Net Income (Loss) Per Common Share In accordance with ASC 260, Earnings Per Share, we allocate earnings or losses to common stockholders and participating securities using the two-class method to compute earnings per share (“EPS”) unless the treasury stock method results in a lower EPS. The two-class method is an earnings allocation formula that treats participating securities as having rights to earnings that otherwise would have been available to common stockholders. Participating securities may participate in undistributed earnings with common stock whether or not that participation is conditioned upon the occurrence of a specified event. Under the two-class method, our net income (loss) is reduced (or increased) by the amount that has been or will be distributed to our participating security holders. We have elected to allocate undistributed income to participating securities based on year-to-date results. Our participating securities, which include preferred stock, do not participate in losses. Basic net income (loss) per common share is computed by dividing net income (loss) allocable to common shares by the weighted average number of common shares outstanding. Diluted net income (loss) per common share includes the effect of warrants, convertible preferred stock, and stock options unless inclusion would not be dilutive.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations In October 2020, we sold our Life Sciences business under the terms of a Stock Purchase Agreement (the “SPA”) with affiliates of American Securities LLC for $753.3 million cash. The Life Sciences business included facilities that were engaged in the production of a variety of components, assemblies, and instruments, such as surgical knives, bioresorbable implants, surgical staples, cases and trays, orthopaedic implants and tools, laparoscopic devices, and drug delivery devices for the orthopaedics and medical/surgical end markets. The sale of the Life Sciences business furthered management’s strategy to improve liquidity and create the financial flexibility to pursue key growth areas in the Mobile Solutions and Power Solutions segments. The SPA included a potential earnout payment of up to $70.0 million based on the performance of the Life Sciences business during the year ended December 31, 2022. Since the sold Life Sciences business did not meet the minimum threshold as defined by the SPA, no earnout payment will be received. After working capital and other closing adjustments, we received cash proceeds at closing of $757.2 million in 2020 and paid $3.9 million to the buyer during the year ended December 31, 2021, for post-closing adjustments. Under the terms of a transition services agreement, we provided certain support services after the sale. In accordance with the terms of the SPA, we agreed to indemnify the buyer for certain tax liabilities on its consolidated federal income tax return related to the Life Sciences business during the portion of the year ended December 31, 2020, prior to the change in ownership on October 6, 2020. We recognized a tax indemnification of $1.2 million during the year ended December 31, 2020 which was reversed during the year ended December 31, 2021, as the actual tax liability was determined to be $0. In accordance with ASC 205-20, Presentation of Financial Statements - Discontinued Operations, the operating results of the Life Sciences business are classified as discontinued operations. The presentation of discontinued operations includes revenues and expenses of the discontinued operations and the gain on the disposition of the business, all net of tax, as one line item on the Consolidated Statements of Operations and Comprehensive Income (Loss). The Consolidated Statements of Operations and Comprehensive Income (Loss) for all periods presented have been revised to reflect this presentation. Accordingly, the results of the Life Sciences business have been excluded from continuing operations and segment results for all periods presented in the consolidated financial statements and the accompanying notes unless otherwise stated. The Consolidated Statements of Cash Flows include cash flows of the Life Sciences business in each line item unless otherwise stated. The following table presents the results of operations of the discontinued operations. Years Ended December 31, 2021 2020 Net sales $ — $ 225,255 Cost of sales (exclusive of depreciation and amortization shown separately below) — 160,464 Selling, general, and administrative expense — 20,779 Depreciation and amortization — 35,731 Goodwill impairment — 146,757 Other operating expense, net — 41 Income from operations — (138,517) Interest expense — 48,893 Loss on extinguishment of debt and write-off of debt issuance costs — 1,388 Other expense, net — (322) Loss from discontinued operations before costs of disposal and benefit for income taxes — (188,476) Benefit for income taxes — 12,468 Loss from discontinued operations before costs of disposal — (176,008) Gain on disposal of discontinued operations 1,200 212,319 Benefit for income taxes on costs of disposal — 2,587 Income (loss) from discontinued operations, net of tax $ 1,200 $ 38,898 During the first quarter of 2020, our market capitalization declined to a level that was less than the net book value of our stockholders’ equity. The decline in market capitalization was a triggering event that caused us to perform a goodwill impairment analysis as of March 31, 2020. The carrying value of the Life Sciences reporting unit exceeded its estimated fair value as of March 31, 2020. As a result of our analysis, we recorded an impairment loss on goodwill of $146.8 million for Life Sciences during the year ended December 31, 2020. The judgments, assumptions, and estimates involved in the goodwill impairment analysis for the Life Sciences reporting unit are consistent with those discussed in Note 7. Our previous credit facility, which was in place at the time, required us to use proceeds from the sale of the Life Sciences business to prepay a portion of our previous debt. We paid $700.0 million in the aggregate on our term loans during the fourth quarter of 2020. The prepayment was applied to debt in accordance with the prepayment provisions of the previous credit agreement, which was in place at the time. Average quarterly interest rates were multiplied by the required prepayment amounts to calculate interest expense to be reclassified to discontinued operations for historical periods presented. The following table summarizes the amount of interest expense related to the previous credit facility that was reclassified to discontinued operations. Years Ended December 31, 2021 2020 Interest on debt $ — $ 35,147 Amortization of debt issuance costs — 13,990 Capitalized interest and other — (244) Total interest expense of discontinued operations $ — $ 48,893 The following table presents the significant noncash items and cash paid for capital expenditures of discontinued operations for each period presented. Years Ended December 31, 2021 2020 Depreciation and amortization $ — $ 35,731 Goodwill impairment — 146,757 Amortization of debt issuance costs — 13,990 Loss on extinguishment of debt and write-off of debt issuance costs — 1,388 Acquisition of property, plant and equipment — 8,416 Right-of-use assets obtained in exchange for new finance lease liabilities — 695 Right-of-use assets obtained in exchange for new operating lease liabilities (1) — 6,174 _______________________________ (1) Includes new leases, renewals, and modifications.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information	Segment Information Our business is aggregated into the following two reportable segments. • Mobile Solutions. Mobile Solutions is focused on growth in the automotive and general industrial end markets. We have developed an expertise in manufacturing highly complex, tight tolerance, system critical components. Our technical capabilities can be utilized in numerous applications including for use in battery electric, hybrid electric, and internal combustion engine vehicles. The group currently manufactures components on a high-volume basis for use in power steering, braking, transmissions, and gasoline fuel system applications, along with components utilized in heating, ventilation and air conditioning and diesel injection and diesel emissions treatment applications. This expertise has been gained through investment in technical capabilities, processes and systems, and allows us to provide skilled program management and product launch capabilities. • Power Solutions. Power Solutions is focused on growth in the electrical, general industrial, automotive, and medical end markets. Within this group we combine materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices used in applications ranging from power control to transportation electrification. We manufacture a variety of products including electrical contacts, connectors, contact assemblies, and precision stampings for the electrical end market and high precision products for the aerospace and defense end market utilizing our extensive process technologies for optical grade plastics, thermally conductive plastics, titanium, Inconel, magnesium, and electroplating. Our medical business includes the production of a variety of tools and instruments for the orthopaedics and medical/surgical end markets. These divisions are considered our two operating segments as each has engaged in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the chief operating decision maker reviews discrete financial information for purposes of allocating resources and assessing performance. The following table presents our financial performance by reportable segment. Year Ended December 31, 2022 2021 2020 Net sales: Mobile Solutions $ 293,536 $ 285,863 $ 256,360 Power Solutions 205,204 191,800 171,269 Corporate and Consolidations (1) (2) (79) (95) Total $ 498,738 $ 477,584 $ 427,534 Income (loss) from operations: Mobile Solutions $ (2,165) $ 9,039 $ 5,228 Power Solutions 3,536 6,493 (85,983) Corporate and Consolidations (22,463) (24,536) (36,702) Total $ (21,092) $ (9,004) $ (117,457) Depreciation and amortization: Mobile Solutions $ 28,192 $ 28,769 $ 28,298 Power Solutions 17,483 15,892 15,730 Corporate and Consolidations 1,556 1,534 1,652 Total $ 47,231 $ 46,195 $ 45,680 Expenditures for long-lived assets: Mobile Solutions $ 14,590 $ 15,411 $ 12,400 Power Solutions 2,401 2,200 2,754 Corporate and Consolidations 961 610 203 Total $ 17,952 $ 18,221 $ 15,357 _______________________________ (1) Includes eliminations of intersegment transactions which occur during the ordinary course of business. The following table summarizes total assets by reportable segment. As of December 31, 2022 2021 Mobile Solutions (1) $ 338,338 $ 357,171 Power Solutions 178,129 184,196 Corporate and Consolidations 29,660 37,734 Total $ 546,127 $ 579,101 _______________________________ (1) Total assets in Mobile Solutions includes $31.8 million and $34.0 million as of December 31, 2022 and 2021, respectively, related to the investment in our 49% owned joint venture (Note 9). The following table summarizes long-lived tangible assets by country. As of December 31, 2022 2021 United States $ 104,360 $ 112,430 China 29,603 32,605 France 24,536 26,977 Mexico 15,235 12,056 Brazil 14,829 15,042 Poland 9,074 9,995 All foreign countries $ 93,277 $ 96,675 Total $ 197,637 $ 209,105

Accounts Receivable

Accounts Receivable	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Accounts Receivable	Accounts Receivable The following table presents changes in the allowance for credit losses. Years Ended December 31, 2022 2021 2020 Balance at beginning of year $ 1,352 $ 2,044 $ 2,044 Additions 326 78 505 Write-offs and other (182) (734) (562) Currency impact (27) (36) 57 Balance at end of year $ 1,469 $ 1,352 $ 2,044 As of December 31, 2022 and 2021, no customer represented greater than 10% of our consolidated accounts receivable balance.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories are comprised of the following amounts: As of December 31, 2022 2021 Raw materials $ 32,146 $ 27,221 Work in process 24,610 24,960 Finished goods 23,926 22,846 Total inventories $ 80,682 $ 75,027

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are comprised of the following amounts: As of December 31, 2022 2021 Land and buildings $ 58,256 $ 57,991 Machinery and equipment 353,364 344,041 Construction in progress 11,063 5,009 Total 422,683 407,041 Less: Accumulated depreciation 225,046 197,936 Property, plant and equipment, net $ 197,637 $ 209,105 For the years ended December 31, 2022, 2021, and 2020, we recorded depreciation expense of $31.4 million, $31.8 million, and $31.3 million, respectively.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill During the first quarter of 2020, our market capitalization declined to a level that was less than the net book value of our stockholders’ equity. The decline in market capitalization was a triggering event that caused us to perform a goodwill impairment analysis as of March 31, 2020. The goodwill impairment analysis required significant judgments to calculate the fair value for the Power Solutions reporting unit, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for each operating segment, and determination of weighted average cost of capital. Our forecasts used in the goodwill impairment analysis reflected our expectations of declines in sales resulting from the COVID-19 pandemic. Significant assumptions and estimates are involved in the application of the discounted cash flow model to forecast operating cash flows, including market growth and market share, sales volumes and prices, costs to produce, discount rate, and estimated capital needs. Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. Assumptions in estimating future cash flows are subject to a high degree of judgment and complexity. The carrying value of the Power Solutions reporting unit exceeded the estimated fair value as of the March 31, 2020, analysis. As a result of our analysis, we recorded an impairment loss on goodwill of $92.9 million to the “Goodwill impairment” line on the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2020. As of December 31, 2022 and 2021, there was no remaining goodwill balance.

Intangible Assets, Net

Intangible Assets, Net	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible Assets The following table shows changes in the carrying amount of intangible assets, net, by reportable segment. Mobile Solutions Power Solutions Total Balance as of December 31, 2020 $ 29,062 $ 74,003 $ 103,065 Amortization (3,353) (10,994) (14,347) Balance as of December 31, 2021 25,709 63,009 88,718 Amortization (3,353) (12,474) (15,827) Balance as of December 31, 2022 $ 22,356 $ 50,535 $ 72,891 The following table shows the cost and accumulated amortization of our intangible assets as of December 31, 2022 and 2021. December 31, 2022 December 31, 2021 Gross Carrying Value as of Acquisition Date Accumulated Net Gross Carrying Value as of Acquisition Date Accumulated Net Customer relationships $ 173,746 $ (103,021) $ 70,725 $ 173,746 $ (87,895) $ 85,851 Trademark and trade name 7,527 (5,361) 2,166 7,527 (4,660) 2,867 Total identified intangible assets $ 181,273 $ (108,382) $ 72,891 $ 181,273 $ (92,555) $ 88,718 At December 31, 2022, the estimated useful life of customer relationships and trademarks and trade names was 5.3 years and 5.7 years, respectively. Intangible assets that are fully amortized are removed and no longer represented in the gross carrying value or accumulated amortization. The following table shows estimated future amortization expense for each of the next five years. Year Ending December 31, 2023 $ 14,167 2024 13,824 2025 13,824 2026 13,824 2027 11,663

Investment in Joint Venture

Investment in Joint Venture	12 Months Ended
	Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]
Investment in Joint Venture	Investment in Joint Venture We own a 49% investment in Wuxi Weifu Autocam Precision Machinery Company, Ltd. (the “JV”), a joint venture located in Wuxi, China. The JV is jointly controlled and managed, and we account for it under the equity method, with the share of net income from the joint venture recorded in the Mobile Solutions segment. The following table shows changes in our investment in the JV. Balance as of December 31, 2021 $ 34,045 Share of earnings 6,592 Dividends paid by joint venture (6,245) Foreign currency translation loss (2,590) Balance as of December 31, 2022 $ 31,802 The following tables show summarized financial information of the unconsolidated JV. Year Ended December 31, 2022 2021 2020 Net sales 101,565 94,846 68,216 Cost of sales 84,654 77,620 56,669 Income from operations 15,111 15,429 10,202 Net income 13,453 12,777 7,401 December 31, 2022 2021 Current assets 63,141 65,465 Noncurrent assets 79,473 75,222 Current liabilities 66,960 67,206 Noncurrent liabilities 8,695 10,006

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table summarizes the income (loss) from continuing operations before benefit (provision) for income taxes and share of net income from joint venture. Years Ended December 31, 2022 2021 2020 United States $ (40,543) $ (35,325) $ (146,963) Foreign 9,474 12,883 (5,125) Loss from continuing operations before benefit (provision) for income taxes and share of net income from joint venture $ (31,069) $ (22,442) $ (152,088) The following table summarizes total income tax expense (benefit) recognized in each year. Years Ended December 31, 2022 2021 2020 Current taxes: U.S. Federal $ (545) $ (19) $ (299) State (625) (615) 4,599 Foreign 4,576 3,014 2,250 Total current tax expense 3,406 2,380 6,550 Deferred taxes: U.S. Federal $ (6,245) $ (8,421) $ (10,368) State 70 (1,099) (5,368) Foreign (986) (154) (1,852) U.S. federal, state and foreign valuation allowance 5,376 5,538 2,066 Total deferred tax benefit (1,785) (4,136) (15,522) Total income tax expense (benefit) $ 1,621 $ (1,756) $ (8,972) The following table presents a reconciliation of income taxes based on the U.S. federal statutory income tax rate. Years Ended December 31, 2022 2021 2020 U.S federal statutory income tax rate 21.0 % 21.0 % 21.0 % Change in valuation allowance, exclusive of state (17.5) % (20.0) % (1.3) % State taxes, net of federal taxes, exclusive of tax reform 1.6 % 4.5 % 0.2 % Non-U.S. earnings taxed at different rates 0.7 % 3.0 % 1.4 % GILTI (3.9) % (6.0) % (0.1) % Goodwill impairment — % — % (12.7) % Deferred true-up (6.4) % — % — % Research and development tax credit 1.5 % 2.3 % 0.4 % Change in uncertain tax positions — % 0.7 % 2.2 % CARES Act — % — % 2.7 % Interest on CARES Act refund 1.8 % — % — % Return to provision 1.3 % 0.8 % (0.5) % Taxes on unremitted foreign earnings (3.9) % 2.0 % (3.9) % Restructuring gain — % — % (2.6) % Intercompany lending (2.7) % (5.3) % — % Warrant revaluation 3.6 % 6.5 % — % Other adjustments, net (2.3) % (1.7) % (0.9) % Effective tax rate (5.2) % 7.8 % 5.9 % Our effective tax rate was (5.2)% for 2022 which differed from the U.S. federal statutory tax rate of 21% primarily due to the impact of our valuation allowance change during the year. Our effective tax rate for continuing operations was 7.8% for 2021. The 2021 effective tax rate for continuing operations differs from the U.S. federal statutory tax rate of 21% primarily due to the impact of our valuation allowance change during the year. Our effective tax rate for continuing operations was 5.9% for 2020. The 2020 effective tax rate for continuing operations differs from the U.S. federal statutory tax rate of 21% primarily due to (1) the impact of the impairment of nondeductible goodwill which is treated as a permanent difference and (2) the accrual of taxes on unremitted earnings of the foreign subsidiaries which may be repatriated. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted. Among other provisions, the CARES Act allows for the carryback of certain tax losses and favorably impacts the deductibility of interest expense and depreciation. The CARES Act had a material impact on our consolidated financial statements, primarily due to enacted federal rate difference in the carryback periods, and has been accounted for in the benefit for income taxes for the year ended December 31, 2020. On October 6, 2020, we sold our Life Sciences business via a sale of our equity interest in Precision Engineered Products Holdings, Inc., a wholly owned U.S. domestic subsidiary. Prior to the sale, we completed tax restructuring in which Precision Engineered Products Holdings, Inc., distributed to NN, Inc., all of its asset and equity holdings related to the Power Solutions segment. The restructuring process created a deferred gain, required to be realized upon the third party equity sale, equal to the fair market value of the distributed assets over tax basis. The associated U.S. federal, state, and foreign tax impacts are reflected in the tables within this footnote. The following table summarizes the principal components of the deferred tax assets and liabilities. As of December 31, 2022 2021 Deferred income tax liabilities: Tax in excess of book depreciation $ 24,045 $ 25,732 Intangible assets 16,978 20,812 Operating leases 10,669 10,473 Interest rate swap 754 37 Taxes on unremitted foreign earnings 4,961 5,630 Other deferred tax liabilities 761 1,007 Total deferred income tax liabilities 58,168 63,691 Deferred income tax assets: Interest expense limitation 10,723 7,141 Goodwill 22,277 24,262 Inventories 2,292 3,368 Section 174 research and development costs 1,859 — Pension and personnel accruals 1,717 2,422 Operating leases 12,852 12,834 Net operating loss carryforwards 24,299 23,629 Credit carryforwards 2,803 3,044 Accruals and reserves 978 1,435 Other deferred tax assets 3,086 4,223 Deferred income tax assets before valuation allowance 82,886 82,358 Valuation allowance on deferred tax assets (30,212) (25,809) Total deferred income tax assets 52,674 56,549 Net deferred income tax liabilities $ 5,494 $ 7,142 As of December 31, 2022, we had a $33.4 million U.S. federal net operating loss (“NOL”) carryover. The federal NOL has an indefinite life, but utilization within any tax year is limited to 80% of taxable income. Therefore, a valuation allowance of $4.4 million has been established to reduce the attribute balance to the amount expected to be utilized. As of December 31, 2022, we had $239.5 million of state NOL carryovers, which begin to expire in 2030. Management believes that certain of the state NOL carryovers will more likely than not expire prior to utilization. As such, a valuation allowance of $15.8 million (prior to federal benefit) has been established to reduce the state attribute balance to the amount expected to be utilized before expiration. We also have $4.8 million, tax-effected, of foreign NOL carryovers at December 31, 2022. The foreign NOLs have an indefinite life; however, management believes that benefit for certain of the foreign NOLs may not be realized. Therefore, we have established a valuation allowance of $1.8 million to reduce the carrying value of the asset related to foreign NOLs to the amount that has been determined to be more likely than not realized. We have $0.2 million and $2.6 million of U.S. federal tax credits and tax credits in foreign jurisdictions, respectively, as of December 31, 2022. We have recognized a valuation allowance of $1.9 million for the foreign tax credits. In addition, we have $2.1 million (prior to federal benefit) of state deferred tax assets for which we believe recognition is not appropriate. We have a U.S. federal and state deferred tax asset related to interest expense carryforwards. Management believes it is more likely than not that the benefit for this assets will not be realized. We have established a valuation allowance of $8.0 million to eliminate the carrying value of this asset. Management assesses available positive and negative evidence to estimate whether it is more likely than not sufficient future taxable income will be generated to provide use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated is cumulative losses incurred over the three-year period ended December 31, 2022. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future earnings growth. On the basis of this evaluation, as of December 31, 2022, a valuation allowance of $30.2 million has been recorded to recognize only the portion of the deferred tax asset that is more likely than not to be realized without consideration of future earnings growth. Management believes all remaining tax assets will more likely than not be realized. However, the amount of the deferred tax asset realized will change based on future conditions, and the amount considered realizable will be adjusted if objective negative evidence in the form of cumulative losses is no longer present allowing additional weight to be given to subjective evidence such as our projections for growth. During 2022, the valuation allowance increased by $4.4 million, primarily due to allowances recorded against U.S. federal net operating loss carryforwards and carryforwards of disallowed interest expense which are subject to certain annual deduction limitations. The increase was partially offset by utilization of previously reserved net operating loss carryforwards in certain foreign jurisdictions, the write-off of deferred tax assets and adjustments to state net operating losses resulting from amended returns for which a full valuation allowance was recorded. As a result of the deemed mandatory repatriation provisions in the U.S. Tax Cuts and Jobs Act of 2017 and subsequent recognition in income of GILTI, we do not have material basis differences related to cumulative unremitted earnings for U.S. income tax purposes. However, we continue to evaluate the impact that repatriation of foreign earnings would have on withholding and other taxes. As of December 31, 2022, we have recorded a liability of $5.0 million for the anticipated withholding taxes that would be due upon repatriation of the unremitted earnings of those subsidiaries for which management does not intend to permanently reinvest. In 2021, the Company asserted that it was permanently reinvested in certain jurisdictions for which it previously was unable to assert permanent reinvestment. Prior to the Company’s debt refinancing in 2021, the Company had recorded a liability on all unremitted earnings. However, upon completion of the debt refinancing, the Company reevaluated repatriation plans, changed its assertion for certain jurisdictions and recorded the resulting tax benefit of $2.4 million. We are subject to U.S. federal income tax as well as tax in several foreign jurisdictions. We are also subject to tax by various state authorities. The tax years subject to examination vary by jurisdiction. We are no longer subject to U.S. federal examination for periods before 2017. We regularly assess the outcomes of both ongoing and future examinations for the current or prior years to ensure our provision for income taxes is sufficient. We recognize liabilities based on estimates of whether additional taxes will be due, and we believe our reserves are adequate in relation to any potential assessments. The outcome of any one examination, some of which may conclude during the next twelve months, is not expected to have a material impact on our financial position or results of operations. Interest and penalties related to federal, state, and foreign income tax matters are recorded as a component of the provision for income taxes in our Consolidated Statements of Operations and Comprehensive Income (Loss). Accrued interest and penalties of $0.5 million, $0.5 million, and $0.6 million are included in other non-current liabilities as of December 31, 2022, 2021, and 2020, respectively. In 2022, we accrued $0.6 million of interest on IRS refunds relating to the CARES Act. We initially filed refund claims in 2021 and will be accruing interest quarterly until refunds are received. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits, excluding interest and penalties. Years Ended December 31, 2022 2021 2020 Balance at beginning of year $ 125 $ 247 $ 2,589 Additions for tax positions of prior years — — 121 Reductions for tax positions of prior years (7) (122) (2,463) Balance at end of year $ 118 $ 125 $ 247 The reduction to unrecognized tax benefits in 2022 is related to the foreign currency remeasurement of previously unrecognized tax benefits. As of December 31, 2022, the unrecognized tax benefits would, if recognized, impact our effective tax rate by $0.6 million, inclusive of the impact of interest and penalties. Management believes that it is reasonably possible that the amount of unrecognized income tax benefits, including interest and penalties, may not decrease during the next twelve months as no statutes are expected to lapse within the period.

Debt

Debt	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt On March 22, 2021, we entered into a new $150.0 million term loan facility (the “Term Loan Facility”) and a new $50.0 million asset backed credit facility (the “ABL Facility”). The following table presents the outstanding debt balances. As of December 31, 2022 2021 Term Loan Facility $ 147,375 $ 148,875 ABL Facility 1,000 — International loans 8,729 10,930 Total principal 157,104 159,805 Less-current maturities of long-term debt 3,321 3,074 Principal, net of current portion 153,783 156,731 Less-unamortized debt issuance costs and discount (1) 4,394 5,679 Long-term debt, net of current portion $ 149,389 $ 151,052 _______________________________ (1) In addition to this amount, costs of $0.6 million and $0.7 million related to the ABL Facility were recorded in other non-current assets as of December 31, 2022 and 2021, respectively. We capitalized interest costs of $0.6 million, $0.3 million, and $0.2 million in the years ended December 31, 2022, 2021, and 2020, respectively, related to construction in progress. Term Loan Facility Outstanding borrowings under the Term Loan Facility bear interest at either 1) one-month LIBOR (subject to a 1.000% floor) plus an applicable margin of 6.875% or 2) the greater of various benchmark rates plus an applicable margin of 5.875%. At December 31, 2022, the Term Loan Facility bore interest, based on one-month LIBOR, at 11.259%. We have an interest rate swap, which expires in July 2024, that changes the one-month LIBOR to a fixed rate of 1.291% on $60.0 million of the outstanding balance of the Term Loan Facility. Refer to Note 19 for further discussion of the interest rate swap agreement. The Term Loan Facility requires quarterly principal payments of $0.4 million with the remaining unpaid principal amount due on the final maturity date of September 22, 2026. We may be required to make additional principal payments annually that are calculated as a percentage of our excess cash flow, as defined by the lender, based on our net leverage ratio. The Term Loan Facility is collateralized by all of our assets. The Term Loan Facility has a first lien on all assets other than accounts receivable and inventory and has a second lien on accounts receivable and inventory. On March 3, 2022, we amended our Term Loan Facility, which increased the quarterly maximum consolidated net leverage ratio. We were in compliance with all requirements under the Term Loan Facility as of December 31, 2022. The Term Loan Facility was issued at a $3.8 million discount and we capitalized an additional $2.8 million in new debt issuance costs. These costs are recorded as a direct reduction to the carrying amount of the associated long-term debt and amortized over the term of the debt. ABL Facility The ABL Facility provides for a senior secured revolving credit facility in the amount of $50.0 million, of which $30.0 million is available in the form of letters of credit and $5.0 million is available for the issuance of short-term swingline loans. The availability of credit under the ABL Facility is limited by a borrowing base calculation derived from accounts receivable and inventory held in the United States. Outstanding borrowings under the ABL Facility bear interest on a variable rate structure plus an interest rate spread that is based on the average amount of aggregate revolving commitment available. The variable borrowing rate is either 1) LIBOR plus an applicable margin of 1.75% or 2.00%, depending on availability, or 2) the greater of the federal funds rate or prime, plus an applicable margin of 0.75% or 1.00%, depending on availability. We may elect whether to use one-month, three-month, or six-month LIBOR, subject to a 0.50% floor. Interest payments are due monthly on borrowings that utilize one-month LIBOR and quarterly on borrowings that utilize three-month or six-month LIBOR. At December 31, 2022, using one-month LIBOR plus a 1.75% spread, the weighted average interest rate on outstanding borrowings under the ABL Facility was 6.00%. We pay a commitment fee of 0.375% for unused capacity under the ABL Facility and a 1.875% fee on the amount of letters of credit outstanding. The final maturity date of the ABL Facility is March 22, 2026. As of December 31, 2022, we had $1.0 million of outstanding borrowings under the ABL Facility, $11.0 million of outstanding letters of credit, and $35.3 million available for future borrowings under the ABL Facility. The ABL Facility has a first lien on accounts receivable and inventory. We were in compliance with all requirements under the ABL Facility as of December 31, 2022. Loan Amendments On March 3, 2023, we amended our Term Loan Facility (the “Term Loan Amendment”) and ABL Facility (the “ABL Amendment”) to adjust certain covenants under the agreements, as well as to change the applicable base rate on which interest expense is determined. The Term Loan Amendment increases the quarterly maximum consolidated net leverage ratio covenant beginning in 2023 and waived the required excess cash flow payment that would have been paid in 2023. The Term Loan Amendment provides for increased utilization of customer programs to accelerate payment terms and also introduces a quarterly domestic liquidity covenant. Interest under the Term Loan Amendment is increased on a paid-in-kind basis at a rate dependent on the Company’s leverage ratio and whether the Company completes a qualifying junior equity raise by June 30, 2023. The Company also issued penny warrants in connection with the Term Loan Amendment. In addition, the base rate for interest expense has been changed from LIBOR to the secured overnight financing rate (“SOFR”). The ABL Amendment provides for increased utilization of customer programs to accelerate payment terms and also introduces a quarterly domestic liquidity covenant. In addition, the base rate for interest expense has been changed from LIBOR to SOFR. Future Maturities The following table lists aggregate maturities of long-term debt for the next five years. Years Ending December 31, 2023 $ 3,321 2024 3,166 2025 3,181 2026 143,887 2027 364

Leases

Leases	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Leases	Leases The following table presents components of lease expense: Years Ended December 31, 2022 2021 2020 Finance lease cost: Amortization of right-of-use assets $ 1,318 $ 1,451 $ 1,272 Interest expense 351 213 192 Operating lease cost 8,285 8,015 8,397 Short-term lease cost (1) 438 655 591 Sublease income (195) — — Total lease cost $ 10,197 $ 10,334 $ 10,452 _______________________________ (1) Excludes expenses related to leases with a lease term of one month or less. The following table presents lease-related assets and liabilities recorded on the balance sheet. As of December 31, Financial Statement Line Item 2022 2021 Assets: Operating lease assets Operating lease right-of-use assets $ 46,713 $ 46,443 Finance lease assets Property, plant and equipment, net 12,989 13,641 Total lease assets $ 59,702 $ 60,084 Liabilities: Current liabilities: Operating lease liabilities Current portion of operating lease liabilities $ 5,294 $ 5,704 Finance lease liabilities Other current liabilities 2,610 3,111 Non-current liabilities: Operating lease liabilities Operating lease liabilities, net of current portion 51,411 51,295 Finance lease liabilities Other non-current liabilities 3,828 5,446 Total lease liabilities $ 63,143 $ 65,556 The following table contains supplemental cash flow information related to leases. Years Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used in finance leases $ 351 $ 213 $ 192 Operating cash flows used in operating leases 14,214 13,434 13,498 Financing cash flows used in finance leases 3,003 4,836 2,018 Right-of-use assets obtained in exchange for new finance lease liabilities $ 1,263 $ 2,814 $ 728 Right-of-use assets obtained in exchange for new operating lease liabilities (1) 5,181 — 8,682 _______________________________ (1) Includes new leases, renewals, and modifications. The weighted average remaining lease term and weighted-average discount rate for finance and operating leases were as follows: As of December 31, 2022 2021 Weighted-average remaining lease term - finance leases 3.1 years 3.3 years Weighted-average remaining lease term - operating leases 10.1 years 11.1 years Weighted-average discount rate - finance leases 5.3 % 3.0 % Weighted-average discount rate - operating leases 7.5 % 7.0 % The maturities of lease liabilities as of December 31, 2022, is as follows: Operating Leases Finance Leases 2023 $ 9,250 $ 2,913 2024 8,419 1,819 2025 8,352 1,017 2026 8,193 950 2027 7,983 509 Thereafter 37,655 — Total future minimum lease payments 79,852 7,208 Less: imputed interest 23,147 770 Total lease liabilities $ 56,705 $ 6,438 In August 2022, we began subleasing a portion of our leased corporate headquarters office space. Since the Company retains the obligation to the lessor, the underlying lease continues to be accounted for as operating leases. Sublease income is recognized on a straight-line basis over the lease terms. In March 2020, we amended the lease of our corporate headquarters building to exit over half of the previously leased space and reduce annual base rent payments. The amendment was accounted for as a lease modification, and the remeasurement of the lease resulted in an $8.1 million decrease in the operating lease ROU asset, a $10.5 million decrease in the noncurrent portion of the operating lease liability, and a $0.6 million decrease in the current portion of the operating lease liability. The $3.0 million difference between the change in the operating lease ROU asset and the operating lease liabilities was recognized in “Other operating expense (income), net,” on the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2020. In connection with the discontinued use of the previously leased space, we also recognized a $4.4 million termination charge and a $2.9 million impairment charge on the associated leasehold improvements, all of which were also recognized in “Other operating expense (income), net” for the year ended December 31, 2020.
Leases	Leases The following table presents components of lease expense: Years Ended December 31, 2022 2021 2020 Finance lease cost: Amortization of right-of-use assets $ 1,318 $ 1,451 $ 1,272 Interest expense 351 213 192 Operating lease cost 8,285 8,015 8,397 Short-term lease cost (1) 438 655 591 Sublease income (195) — — Total lease cost $ 10,197 $ 10,334 $ 10,452 _______________________________ (1) Excludes expenses related to leases with a lease term of one month or less. The following table presents lease-related assets and liabilities recorded on the balance sheet. As of December 31, Financial Statement Line Item 2022 2021 Assets: Operating lease assets Operating lease right-of-use assets $ 46,713 $ 46,443 Finance lease assets Property, plant and equipment, net 12,989 13,641 Total lease assets $ 59,702 $ 60,084 Liabilities: Current liabilities: Operating lease liabilities Current portion of operating lease liabilities $ 5,294 $ 5,704 Finance lease liabilities Other current liabilities 2,610 3,111 Non-current liabilities: Operating lease liabilities Operating lease liabilities, net of current portion 51,411 51,295 Finance lease liabilities Other non-current liabilities 3,828 5,446 Total lease liabilities $ 63,143 $ 65,556 The following table contains supplemental cash flow information related to leases. Years Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used in finance leases $ 351 $ 213 $ 192 Operating cash flows used in operating leases 14,214 13,434 13,498 Financing cash flows used in finance leases 3,003 4,836 2,018 Right-of-use assets obtained in exchange for new finance lease liabilities $ 1,263 $ 2,814 $ 728 Right-of-use assets obtained in exchange for new operating lease liabilities (1) 5,181 — 8,682 _______________________________ (1) Includes new leases, renewals, and modifications. The weighted average remaining lease term and weighted-average discount rate for finance and operating leases were as follows: As of December 31, 2022 2021 Weighted-average remaining lease term - finance leases 3.1 years 3.3 years Weighted-average remaining lease term - operating leases 10.1 years 11.1 years Weighted-average discount rate - finance leases 5.3 % 3.0 % Weighted-average discount rate - operating leases 7.5 % 7.0 % The maturities of lease liabilities as of December 31, 2022, is as follows: Operating Leases Finance Leases 2023 $ 9,250 $ 2,913 2024 8,419 1,819 2025 8,352 1,017 2026 8,193 950 2027 7,983 509 Thereafter 37,655 — Total future minimum lease payments 79,852 7,208 Less: imputed interest 23,147 770 Total lease liabilities $ 56,705 $ 6,438 In August 2022, we began subleasing a portion of our leased corporate headquarters office space. Since the Company retains the obligation to the lessor, the underlying lease continues to be accounted for as operating leases. Sublease income is recognized on a straight-line basis over the lease terms. In March 2020, we amended the lease of our corporate headquarters building to exit over half of the previously leased space and reduce annual base rent payments. The amendment was accounted for as a lease modification, and the remeasurement of the lease resulted in an $8.1 million decrease in the operating lease ROU asset, a $10.5 million decrease in the noncurrent portion of the operating lease liability, and a $0.6 million decrease in the current portion of the operating lease liability. The $3.0 million difference between the change in the operating lease ROU asset and the operating lease liabilities was recognized in “Other operating expense (income), net,” on the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2020. In connection with the discontinued use of the previously leased space, we also recognized a $4.4 million termination charge and a $2.9 million impairment charge on the associated leasehold improvements, all of which were also recognized in “Other operating expense (income), net” for the year ended December 31, 2020.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Brazil ICMS Tax Matter Prior to the acquisition of Autocam Corporation (“Autocam”) in 2014, Autocam’s Brazilian subsidiary (“Autocam Brazil”) received notification from the Brazilian tax authority regarding ICMS (state value added tax) tax credits claimed on intermediary materials (e.g., tooling and perishable items) used in the manufacturing process. The Brazilian tax authority notification disallowed state ICMS tax credits claimed on intermediary materials based on the argument that these items are not intrinsically related to the manufacturing processes. Autocam Brazil filed an administrative defense with the Brazilian tax authority arguing, among other matters, that it should qualify for an ICMS tax credit, contending that the intermediary materials are directly related to the manufacturing process. We believe that we have substantial legal and factual defenses, and we plan to defend our interests in this matter vigorously. The matter encompasses several lawsuits filed with the Brazilian courts requesting declaratory actions that no tax is due or seeking a stay of execution on the collection of the tax. In 2018, we obtained a favorable decision in one of the declaratory actions for which the period for appeal has expired. We have filed actions in each court requesting dismissal of the matter based on the earlier court action. In May 2020, we received an unfavorable decision in one of the lawsuits, and as a result have recorded a liability to the Brazilian tax authorities and a receivable from the former shareholders of Autocam for the same amount. Although we anticipate a favorable resolution to the remaining matters, we can provide no assurances that we will be successful in achieving dismissal of all pending cases. The U.S. dollar amount that would be owed in the event of an unfavorable decision is subject to interest, penalties, and currency impacts and therefore is dependent on the timing of the decision. For the remaining open lawsuits, we currently believe the cumulative potential liability in the event of unfavorable decisions on all matters will be less than $5.0 million, inclusive of interest and penalties. We are entitled to indemnification from the former shareholders of Autocam, subject to the limitations and procedures set forth in the agreement and plan of merger relating to the Autocam acquisition. Management believes the indemnification would include amounts owed for the tax, interest, and penalties related to this matter. Accordingly, we do not expect to incur a loss related to this matter even in the event of an unfavorable decision and, therefore, have not accrued an amount for the remaining matters as of December 31, 2022. Securities Offering Matter On November 1, 2019, Erie County Employees’ Retirement System, on behalf of a purported class of plaintiffs, filed a complaint in the Supreme Court of the State of New York, County of New York against us, certain of our current and former officers and directors, and each of the underwriters involved in our public offering and sale of 14.4 million shares of our common stock pursuant to a preliminary prospectus supplement, dated September 10, 2018, a final prospectus supplement, dated September 13, 2018, and a base prospectus, dated April 19, 2017, relating to our effective shelf registration statement on Form S-3 (File No. 333-216737) (the “Offering”). The amended complaint alleged violations of Sections 11, 12(a)(2), and 15 of the Securities Act in connection with the Offering. On July 25, 2022, the parties filed a Stipulation of Settlement to settle the securities offering action. Under the terms of the Stipulation of Settlement, which was approved and finalized by the court on December 1, 2022, the Company and/or its insurance carriers were to make cash payments to the plaintiff in the amount of $9.5 million (the “Settlement Amount”), in exchange for which the Company and the other named defendants were released from all claims related to the securities offering action. Since we had previously paid covered expenses totaling $1.0 million meeting our directors' and officers' retention requirement, the Settlement Amount was covered and paid by our directors' and officers' insurance carriers during the fourth quarter of 2022. Other Legal Matters On April 25, 2022, we reached an agreement to settle breach of contract claims brought by a former customer regarding the sale of products by us in 2016. Under the agreement, we are paying $1.8 million to the customer in specified installments through July 2023. The $1.8 million settlement is included in the “Other operating expense (income), net” line in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Preferred Stock and Stockholder

Preferred Stock and Stockholders' Equity	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Preferred Stock and Stockholders' Equity	Preferred Stock and Stockholders' Equity Series D Perpetual Preferred Stock On March 22, 2021, we completed a private placement of 65,000 shares of newly designated Series D Perpetual Preferred Stock, with a par value of $0.01 per share (the “Series D Preferred Stock”), at a price of $1,000 per share, together with detachable warrants (the “2021 Warrants”) to purchase up to 1.9 million shares of our common stock at an exercise price of $0.01 per share. The Series D Preferred Stock has an initial liquidation preference of $1,000 per share and is redeemable at our option in cash at a redemption price equal to the liquidation preference then in effect. Series D Preferred Stock shares earn cash dividends at a rate of 10.0% per year, payable quarterly in arrears, accruing whether or not earned or declared. If no cash dividend is paid, then the liquidation preference per share effective on the dividend date increases by 12.0% per year. On March 22, 2026, the cash dividend rate and in-kind dividend rate increase by 2.5% per year. Cash dividends are required beginning on September 30, 2027. The Series D Preferred Stock is classified as mezzanine equity, between liabilities and stockholders’ equity, because certain features of the Series D Preferred Stock could require redemption of the Series D Preferred Stock upon a change of control event that is considered not solely within our control. For initial recognition, the Series D Preferred Stock was recognized at a discounted value, net of issuance costs and allocation to warrants and a bifurcated embedded derivative. The aggregate discount is amortized as a deemed dividend through March 22, 2026, which is the date the dividend rate begins to increase by 2.5% per year. Deemed dividends adjust retained earnings (or in the absence of retained earnings, additional paid-in capital). In accordance with ASC 815-15, Derivatives and Hedging - Embedded Derivatives, certain features of the Series D Preferred Stock were bifurcated and accounted for as derivatives separately. Note 19 discusses the accounting for these features. As of December 31, 2022, the carrying value of the Series D Preferred Stock shares was $64.7 million, which included $18.0 million of accumulated unpaid and deemed dividends. The following table presents the change in the Series D Preferred Stock carrying value. Years Ended December 31, 2022 2021 Balance at beginning of year $ 53,807 $ — Proceeds from issuance of shares, net of issuance costs — 61,793 Fair value of 2021 Warrants issued — (14,839) Recognition of bifurcated embedded derivative — (282) Accrual of in-kind dividends 8,961 6,222 Amortization 1,933 913 Balance at end of year $ 64,701 $ 53,807 Net cash proceeds of $61.8 million from the issuance of the Series D Preferred Stock, along with part of the proceeds from the Term Loan Facility, were used to redeem all of the outstanding shares of the Company’s Series B Convertible Preferred Stock (the “Series B Preferred Stock”). Series B Convertible Preferred Stock The Series B Preferred Stock had a liquidation preference of $1,000 per share and was redeemable in cash at our option, subject to the applicable redemption premium. Series B Preferred Stock shares earned cumulative dividends at a rate of 10.625% per year, and accrued whether or not earned or declared. The Series B Preferred Stock was recognized at a discounted value, net of issuance costs and allocation to warrants and bifurcated embedded derivatives. The aggregate discount was amortized as a deemed dividend through December 31, 2023, which is the date the holders had a non-contingent conversion option into a variable number of common shares equal to the liquidation preference plus accrued and unpaid dividends. Deemed dividends adjust retained earnings (or in the absence of retained earnings, additional paid-in capital). At redemption on March 22, 2021, the carrying value of the Series B Preferred Stock shares included $14.3 million of accumulated unpaid and deemed dividends. The following table presents the change in the Series B Preferred Stock carrying value. Years Ended December 31, 2021 2020 Balance at beginning of year $ 105,086 $ 93,012 Accrual of in-kind dividends 14,008 11,121 Amortization 335 953 Redemption (119,429) — Balance at end of year $ — $ 105,086

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customers	Revenue from Contracts with Customers Revenue is recognized when control of the good or service is transferred to the customer either at a point in time or, in limited circumstances, as our services are rendered over time. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or services. During the year ended December 31, 2022, we received equipment from a customer as part of the selling price of goods transferred. This noncash consideration was recognized as revenue equal to the fair value of the equipment received. The following tables summarize revenue by customer geographical region. Year Ended December 31, 2022 Mobile Power Intersegment Total United States and Puerto Rico $ 140,931 $ 160,894 $ (2) $ 301,823 China 46,045 5,511 — 51,556 Brazil 47,266 950 — 48,216 Mexico 23,348 17,297 — 40,645 Germany 5,158 348 — 5,506 Poland 5,031 11 — 5,042 Other 25,757 20,193 — 45,950 Total net sales $ 293,536 $ 205,204 $ (2) $ 498,738 Year Ended December 31, 2021 Mobile Power Intersegment Total United States and Puerto Rico $ 140,383 $ 152,931 $ (79) $ 293,235 China 52,227 4,745 — 56,972 Brazil 34,644 811 — 35,455 Mexico 19,520 16,177 — 35,697 Germany 5,230 546 — 5,776 Poland 3,743 18 — 3,761 Other 30,116 16,572 — 46,688 Total net sales $ 285,863 $ 191,800 $ (79) $ 477,584 Year Ended December 31, 2020 Mobile Power Intersegment Total United States and Puerto Rico $ 129,147 $ 139,499 $ (95) $ 268,551 China 46,442 5,563 — 52,005 Brazil 27,055 689 — 27,744 Mexico 16,465 13,400 — 29,865 Germany 5,846 378 — 6,224 Poland 4,913 14 — 4,927 Other 26,492 11,726 — 38,218 Total net sales $ 256,360 $ 171,269 $ (95) $ 427,534 The following tables summarize revenue by customer industry. Our products in the automotive industry include high-precision components and assemblies for electric power steering systems, electric braking, electric motors, fuel systems, emissions control, transmissions, moldings, stampings, sensors, and electrical contacts. Our products in the general industrial industry include high-precision metal and plastic components for a variety of industrial applications including diesel industrial motors, heating and cooling systems, fluid power systems, power tools, and more. While many of the industries we serve include electrical components, our products in the residential/commercial electrical industry category in the following tables include components used in smart meters, charging stations, circuit breakers, transformers, electrical contact assemblies, precision stampings, welded contact assemblies, and specification plating and surface finishing. Year Ended December 31, 2022 Mobile Power Intersegment Total Automotive $ 197,341 $ 40,890 $ — $ 238,231 General Industrial 78,142 61,828 — 139,970 Residential/Commercial Electrical — 70,055 — 70,055 Other 18,053 32,431 (2) 50,482 Total net sales $ 293,536 $ 205,204 $ (2) $ 498,738 Year Ended December 31, 2021 Mobile Power Intersegment Total Automotive $ 182,094 $ 38,779 $ — $ 220,873 General Industrial 90,290 60,312 — 150,602 Residential/Commercial Electrical — 61,748 — 61,748 Other 13,479 30,961 (79) 44,361 Total net sales $ 285,863 $ 191,800 $ (79) $ 477,584 Year Ended December 31, 2020 Mobile Power Intersegment Total Automotive $ 170,389 $ 31,422 $ — $ 201,811 General Industrial 75,610 52,714 — 128,324 Residential/Commercial Electrical — 58,143 — 58,143 Other 10,361 28,990 (95) 39,256 Total net sales $ 256,360 $ 171,269 $ (95) $ 427,534 Other Sources of Revenue We provide pre-production activities related to engineering efforts to develop molds, dies, and machines that are owned by our customers. We may receive advance payments from customers which are deferred until satisfying our performance obligations by compliance with customer-specified milestones, recognizing revenue at a point in time. These contracts generally have an original expected duration of less than one year. Deferred Revenue The timing of revenue recognition, billings, and cash collections results in billed accounts receivable and customer advances and deposits (e.g. contract liability) on the Consolidated Balance Sheets. These contract liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period as deferred revenue, which is reported in the “Other current liabilities” line on the Consolidated Balance Sheets. Deferred revenue relates to payments received in advance of performance under the contract and recognized as revenue as (or when) we perform under the contract. Changes in the contract liability balances during the year ended December 31, 2022, were not materially impacted by any other factors. The balance of deferred revenue was $0.7 million and $0.5 million as of December 31, 2022 and December 31, 2021, respectively. Revenue recognized for performance obligations satisfied or partially satisfied during the year ended December 31, 2022 included $0.5 million that was included in deferred revenue as of December 31, 2021. Transaction Price Allocated to Future Performance Obligations We are required to disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of December 31, 2022, unless our contracts meet one of the practical expedients. Our contracts met the practical expedient for a performance obligation that is part of a contract that has an original expected duration of one year or less. Costs to Obtain and Fulfill a Contract We recognize commissions paid to internal sales personnel that are incremental to obtaining customer contracts as an expense when incurred since the amortization period is less than one year. Costs to obtain a contract are expensed as selling, general and administrative expense. Sales, VAT, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. Sales Concentration No single customer accounted for 10% or more of consolidated net sales, during the years ended December 31, 2022, 2021, and 2020.

Share-Based Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation As of December 31, 2022, we have 3.4 million shares available that can be issued to employees and non-executive directors under the 2022 Omnibus Incentive Plan as options, stock appreciation rights, and other share-based awards. Shares of our common stock delivered upon exercise or vesting may consist of newly issued shares of our common stock or shares acquired in the open market. Share-based compensation expense is recognized in the “Selling, general, and administrative expense” line in the Consolidated Statements of Operations and Comprehensive Income (Loss) except for $0.8 million attributable to discontinued operations for the year ended December 31, 2020. The following table lists the components of share-based compensation expense by type of award. Years Ended December 31, 2022 2021 2020 Restricted stock 3,635 2,166 3,393 Performance share units 602 797 199 Stock options $ 140 $ 253 $ 634 Share-based compensation expense $ 4,377 $ 3,216 $ 4,226 Unrecognized compensation cost related to unvested awards was $3.1 million as of December 31, 2022, which will be recognized over a weighted-average period of 1.7 years. Restricted Stock During the years ended December 31, 2022, 2021, and 2020, we granted 897,000, 459,000, and 460,000 shares of restricted stock to non-executive directors, officers, and certain other key employees. Shares of restricted stock vest pro-rata generally over three years for employees and over one year for non-executive directors. The fair value of restricted stock awards is based on the closing price of our common stock as of the date of grant. The weighted average grant-date fair value of restricted stock granted in the years ended December 31, 2022, 2021, and 2020, was $3.31, $6.84, and $9.35 per share, respectively. The total grant-date fair value of restricted stock that vested in the years ended December 31, 2022, 2021, and 2020, was $2.1 million, $2.8 million, and $1.9 million, respectively. The following table presents the status of unvested restricted stock awards as of December 31, 2022 and changes during the year then ended. Nonvested Weighted Average Grant-Date Unvested at January 1, 2022 469,000 $ 7.28 Granted 897,000 3.31 Vested (291,000) 7.05 Forfeited (37,000) 3.93 Unvested at December 31, 2022 1,038,000 $ 4.03 Performance Share Units Performance Share Units (“PSUs”) are a form of long-term incentive compensation awarded to executive officers and certain other key employees designed to directly align the interests of employees to the interests of our stockholders, and to create long-term stockholder value. Some PSUs are based on total shareholder return (“TSR Awards”), and other PSUs are based on return on invested capital (“ROIC Awards”). TSR Awards granted in 2022, 2021, and 2020 were made pursuant to the 2019 Omnibus Plan and a Performance Share Unit Agreement (the “2019 Omnibus Agreement”). ROIC Awards granted in 2022 were made pursuant to the 2022 Omnibus Incentive Plan and a Performance Share Unit Agreement. ROIC Awards granted in 2021 and 2020 were made pursuant to the 2019 Omnibus Agreement. The TSR Awards vest, if at all, upon our achieving a specified relative total shareholder return, which will be measured against the total shareholder return of a specified index during specified performance periods as defined in the 2019 Omnibus Agreement. The ROIC Awards vest, if at all, upon our achieving a specified average return on invested capital during the performance periods. Each performance period generally begins on January 1 of the year of grant and ends 3 years later on December 31. If the PSUs do not vest at the end of the performance periods, then the PSUs will expire automatically. PSUs that vest will be settled by the issuance of shares of our common stock with the actual number of shares interpolated between a threshold and maximum payout amount based on actual performance results. No dividends will be paid on outstanding PSUs during the performance period; however, dividend equivalents will be paid based on the number of shares of common stock that are ultimately earned at the end of the performance periods. A participant will earn 25% or 50% of the target number of PSUs for “Threshold Performance,” 100% of the target number of PSUs for “Target Performance,” and 150% of the target number of PSUs for “Maximum Performance.” For performance levels falling between the values shown below, the percentages will be determined by interpolation. The following tables present the goals with respect to TSR Awards and ROIC Awards granted in 2022, 2021, and 2020. TSR Awards: Threshold Performance (25% or 50% of Shares) (1) Target Performance Maximum Performance 2022 grants 25 th Percentile 55 th Percentile 75 th Percentile 2021 grants 35 th Percentile 50 th Percentile 75 th Percentile 2020 grants 35 th Percentile 50 th Percentile 75 th Percentile ROIC Awards: Threshold Performance Target Performance Maximum Performance 2022 grants 6.4 % 8.6 % 10.0 % 2021 grants 6.3 % 7.0 % 8.6 % 2020 grants 6.7 % 7.9 % 8.7 % _______________________________ (1) Threshold performance will earn 25% of the target number of PSUs for the 2022 grants and 50% for the 2021 grants and 2020 grants. The following table presents the number of PSUs granted and the grant-date fair value of each award in the periods presented. TSR Awards ROIC Awards Award Year Performance Units Grant-Date Performance Units Grant-Date 2022 382,000 $ 2.53 408,000 $ 2.62 2021 142,000 $ 8.58 172,000 $ 7.20 2020 139,000 $ 10.88 157,000 $ 9.44 The grant-date fair value of TSR Awards is determined using the Monte Carlo simulation model, as the total shareholder return metric is considered a market condition under ASC Topic 718, Compensation – stock compensation , and expense is recognized over the performance period regardless of actual award payout. The grant-date fair value of ROIC Awards is based on the closing price of a share of our common stock on the date of grant and compensation expense is recognized over the performance period based on the estimated outcome of the performance condition. The following table presents the status of unvested PSUs as of December 31, 2022 and changes during the year then ended. Nonvested TSR Awards Nonvested ROIC Awards Number of Performance Units Weighted Average Grant-Date Number of Performance Units Weighted Average Grant-Date Nonvested at January 1, 2022 194,000 $ 9.59 228,000 $ 8.14 Granted 382,000 2.53 408,000 2.62 Expired (84,000) 10.88 (96,000) 9.44 Nonvested at December 31, 2022 492,000 $ 3.87 540,000 $ 3.74 None of the PSUs that were granted in 2018, 2019, and 2020 vested in 2020, 2021, and 2022, respectively, because the actual performance achieved was below the “Threshold Performance” level as defined by the grant agreements. Stock Options Stock options have an exercise price equal to the closing price of our stock on the date of grant, an exercise term of ten years with a vesting period of three years. No options were granted in 2022 or 2021. We granted 159,000 options during the year ended December 31, 2020 with a weighted average grant-date fair value of $4.76 per share. The following table presents stock option activity for the year ended December 31, 2022. Number of Options Weighted-Average Weighted-Average Remaining Contractual Term Aggregate Outstanding at January 1, 2022 621,000 $ 12.24 Forfeited (4,000) 9.44 Expired (79,000) 9.71 Outstanding at December 31, 2022 538,000 $ 12.63 3.0 years $ — (1) Exercisable at December 31, 2022 515,000 $ 12.77 2.8 years $ — (1) _______________________________ (1) The aggregate intrinsic value is the sum of intrinsic values for each exercisable individual option grant. The intrinsic value is the amount by which the closing market price of our stock at December 31, 2022, was greater than the exercise price of any individual option grant.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Income The components of accumulated other comprehensive income (loss) (“AOCI”) are as follows: Foreign Currency Translation Interest rate swap Income taxes (1) Total Balance as of December 31, 2019 $ (35,159) $ (12,234) $ 2,839 $ (44,554) Other comprehensive income (loss) before reclassifications (1,683) (16,207) 3,764 (14,126) Amounts reclassified from AOCI to interest expense (2) — 8,906 (2,068) 6,838 Amounts reclassified from AOCI to loss on interest rate swap (3) — 15,823 (3,674) 12,149 Sale of discontinued operations 5,961 — — 5,961 Net other comprehensive income (loss) 4,278 8,522 (1,978) 10,822 Balance as of December 31, 2020 $ (30,881) $ (3,712) $ 861 $ (33,732) Other comprehensive income (loss) before reclassifications (1,135) 78 (19) (1,076) Amounts reclassified from AOCI to interest expense (2) — 73 (18) 55 Amounts reclassified from AOCI to loss on interest rate swap (3) — 3,712 (861) 2,851 Net other comprehensive income (loss) (1,135) 3,863 (898) 1,830 Balance as of December 31, 2021 $ (32,016) $ 151 $ (37) $ (31,902) Other comprehensive income (loss) before reclassifications (8,156) 3,426 (68) (4,798) Amounts reclassified from AOCI to interest expense (2) — (428) 8 (420) Net other comprehensive income (loss) (8,156) 2,998 (60) (5,218) Balance as of December 31, 2022 $ (40,172) $ 3,149 $ (97) $ (37,120) _______________________________ (1) Income tax effect of changes in interest rate swap. (2) Represents interest rate swap settlements of effective hedge. (3) Represents reclassification of derivative loss and settlements after discontinuation of hedge accounting. See Note 19 for further discussion of the interest rate swap.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Common Share The following table summarizes the computation of basic and diluted net income (loss) per common share. Years Ended December 31, 2022 2021 2020 Numerator: Loss from continuing operations $ (26,098) $ (14,425) $ (139,490) Adjustment for preferred stock cumulative dividends and deemed dividends (10,894) (21,478) (12,373) Numerator for basic and diluted net loss from continuing operations per common share (36,992) (35,903) (151,863) Income from discontinued operations, net of tax — 1,200 38,898 Numerator for basic and diluted net loss per common share $ (36,992) $ (34,703) $ (112,965) Denominator: Weighted average common shares outstanding 43,738 42,991 42,692 Adjustment for participating securities (951) (461) (493) Adjustment for 2021 Warrants outstanding (1) 1,893 1,481 — Shares used to calculate basic and diluted net loss per share 44,680 44,011 42,199 Per common share net income (loss): Basic and diluted net loss from continuing operations per common share $ (0.83) $ (0.82) $ (3.60) Basic and diluted net income from discontinued operations per common share — 0.03 0.92 Basic and diluted net loss per common share $ (0.83) $ (0.79) $ (2.68) Cash dividends declared per common share $ — $ — $ — _______________________________ (1) Weighted average 2021 Warrants outstanding are included in shares outstanding for calculation of basic earnings per share because they are exercisable at an exercise price of $0.01 per share, subject to certain adjustments (see Note 19). The following table presents potentially dilutive securities that were excluded from the calculation of diluted net income (loss) per common share because they had an anti-dilutive effect. Years Ended December 31, 2022 2021 2020 Options 557 766 871 2019 Warrants 1,500 1,500 1,500 Series B Preferred Stock, as-converted — — 19,021 2,057 2,266 21,392

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is an exit price representing the expected amount that an entity would receive to sell an asset or pay to transfer a liability in an orderly transaction with market participants at the measurement date. We followed consistent methods and assumptions to estimate fair values as more fully described in Note 1. Preferred Stock Related Derivatives Certain features were bifurcated and accounted for separately from the Series B Preferred Stock. The following features were recorded as derivatives. • Warrants. In conjunction with our placement of the Series B Preferred Stock, we issued detachable warrants to purchase up to 1.5 million shares of our common stock (the “2019 Warrants”), which are exercisable, in full or in part, at any time prior to December 11, 2026. The original exercise price was $12.00 per share, subject to anti-dilution adjustments in the event of future below market issuances, stock splits, stock dividends, combinations or similar events. The issuance of the 2021 Warrants resulted in an adjusted exercise price of $11.49 per share for the 2019 Warrants because the new warrants have an exercise price below market value. Certain features were bifurcated and accounted for separately from the Series D Preferred Stock. The following features were recorded as derivatives. • Warrants. In conjunction with our placement of the Series D Preferred Stock, we issued detachable warrants to purchase up to 1.9 million shares of our common stock. The 2021 Warrants are exercisable, in full or in part, at any time prior to March 22, 2027, at an exercise price of $0.01 per share, subject to anti-dilution adjustments in the event of certain future equity issuances, stock splits, stock dividends, combinations or similar events. • Change-in-control put feature. The Series D Preferred Stock includes a put feature that allows the holder to redeem the Series D Preferred Stock upon a change in control at the greater of 1) the liquidation preference plus accrued dividends or 2) 140% of the liquidation preference. The put feature is considered a redemption right at a premium and is not clearly and closely related to the debt host. The following table presents the changes in liability balance of the preferred stock related derivatives. Years Ended December 31, 2022 2021 Balance at beginning of year $ 8,224 $ 3,117 Issuances — 15,121 Change in fair value (1) (5,265) (7,009) Settlements — (3,005) Balance at end of year $ 2,959 $ 8,224 _______________________________ (1) Changes in the fair value are recognized in the “Other income, net” line in the Consolidated Statements of Operations and Comprehensive Income (Loss). The following tables show the fair values of the preferred stock related derivatives within the fair value hierarchy. December 31, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative liability - other non-current liabilities 2,831 — 128 December 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative liability - other non-current liabilities 7,771 — 453 The fair value of the 2019 Warrants is determined using a valuation model that utilizes unobservable inputs to determine the probability that the 2019 Warrants will remain outstanding for future periods. The probabilities resulted in a weighted average term of 2.9 years as of December 31, 2022 and 3.6 years as of December 31, 2021. The fair value of the 2021 Warrants is determined using the observable market price of a share of our common stock, less the $0.01 per share exercise price. The fair value of the change-in-control put feature utilizes unobservable inputs based on the Company’s assessment of the probability of a change-in-control event occurring in a future period. The probability of a change-in-control event ranged from 3% to 10% as of December 31, 2022 and 1% to 10% as of December 31, 2021. Interest Rate Swaps We manage our exposure to fluctuations in interest rates using a mix of fixed and variable rate debt. We utilize fixed-rate interest rate swap agreements to change the variable interest rate to a fixed rate on a portion of our variable rate debt. On July 22, 2021, we entered into a fixed-rate interest rate swap agreement to change the LIBOR-based component of the interest rate on a portion of our variable rate debt to a fixed rate of 1.291% (the “2021 Swap”). The 2021 Swap has a notional amount of $60.0 million and a maturity date of July 31, 2024. The objective of the 2021 Swap is to eliminate the variability of cash flows in interest payments on the first $60.0 million of variable rate debt attributable to changes in benchmark one-month LIBOR interest rates. The hedged risk is the interest rate risk exposure to changes in interest payments, attributable to changes in benchmark one-month LIBOR interest rates over the interest rate swap term. The changes in cash flows of the interest rate swap are expected to exactly offset changes in cash flows of the variable rate debt. We designated the 2021 Swap as a cash flow hedge at inception. Cash settlements of the 2021 Swap are recognized in interest expense. On February 8, 2019, we entered into a $700.0 million fixed-rate interest rate swap agreement that changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575% (the “2019 Swap”). On March 22, 2021, we terminated the 2019 Swap with a $13.7 million cash payment in connection with the extinguishment of our previously outstanding long-term variable-rate debt. The 2019 Swap was designated as a cash flow hedge at inception. However, in the fourth quarter of 2020, the 2019 Swap no longer qualified as an effective hedge, and subsequent changes in fair value of the 2019 Swap were recognized in earnings. Amounts recognized in earnings related to the 2019 Swap are recorded in the “Loss on interest rate swap” line on the Consolidated Statements of Operations and Comprehensive Income (Loss) except that cash settlements prior to termination are recognized in “Derivative payments on interest rate swap.” Cash settlements during 2021 and the fourth quarter of 2020 are presented in investing activities on the Consolidated Statements of Cash Flows. The following table presents the effect of the interest rate swaps on the Consolidated Statements of Operations and Comprehensive Income (Loss). Years Ended December 31, 2022 2021 2020 Interest expense (benefit) (1) $ (428) $ 73 $ 8,906 Derivative payments on interest rate swap (2) — 1,717 4,133 Loss on interest rate swap (2) — 2,033 11,669 _______________________________ (1) Represents settlements on the interest rate swaps while the hedges are effective. (2) Represents settlements and changes in fair value on the 2019 Swap while the hedge was ineffective. As of December 31, 2022 and 2021, we reported a $3.1 million gain and a $0.1 million gain, respectively, net of tax, in accumulated other comprehensive income related to the interest rate swap. The following tables show the fair values of the interest rate swaps within the fair value hierarchy. December 31, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative asset - other current assets $ — $ 2,130 $ — Derivative asset - other non-current assets — 1,023 — Total $ — $ 3,153 $ — December 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative asset - other non-current assets $ — $ 284 $ — Derivative liability - other current liabilities — (129) — Total $ — $ 155 $ — The fair value of the interest rate swap is calculated through standard pricing models which use inputs derived from or corroborated by observable market data such as interest rate yield curves, index forward curves, discount curves, and volatility surfaces. The counterparty to these derivative contracts is a highly rated financial institution which we believe carries only a minimal risk of nonperformance. Fair Value Disclosures

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Business	Nature of Business NN, Inc. is a diversified industrial company that combines in-depth materials science expertise with advanced engineering and production capabilities to design and manufacture high-precision metal and plastic components and assemblies for a variety of end markets on a global basis. As used in this Annual Report on Form 10-K (this “Annual Report”), the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries. We have 31 facilities in North America, Europe, South America, and Asia.
Basis of Presentation	Basis of PresentationThe accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Certain prior period amounts have been reclassified to conform to the current year’s presentation. Except for per share data or as otherwise indicated, all U.S. dollar amounts presented in the tables in these Notes to Consolidated Financial Statements are in thousands.
Principles of Consolidation	Principles of Consolidation Our consolidated financial statements include the accounts of NN, Inc., and its wholly owned subsidiaries. We own a 49% interest in a joint venture which we account for using the equity method (see Note 9). All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates in the Preparation of Consolidated Financial Statements	Use of Estimates in the Preparation of Consolidated Financial Statements The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to use estimates and assumptions that affect the reported amounts of certain assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates.
Accounting Standards Not Yet Adopted
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash and highly liquid investments with original maturities of three months or less. We maintain cash balances in transaction accounts with various financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). Although we maintain balances that exceed the federally insured limit, we have not experienced any losses related to these balances, and we believe credit risk to be minimal. We had $12.5 million and $17.6 million in cash and cash equivalents as of December 31, 2022 and 2021, respectively, held at foreign financial institutions.
Fair Value Measurements	Fair Value Measurements Fair value principles prioritize valuation inputs across three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the assumptions used to measure assets and liabilities at fair value. An asset or liability’s classification within the various levels is determined based on the lowest level input that is significant to the fair value measurement.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are recorded at their net realizable value. We maintain allowances for estimated losses resulting from the inability of our customers to make required payments. The allowances are based on the amount that we ultimately expect to collect from our customers. We evaluate the collectability of accounts receivable based on a combination of factors including number of days receivables are past due, historical collection experience, current market conditions, and forecasted direction of economic and business environment. Accounts receivable are written off at the time a customer receivable is deemed uncollectible.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using standard costs, which approximates the average cost method. Our policy is to expense abnormal amounts of idle facility expense, freight, handling cost, and waste included in cost of products sold. In addition, we allocate fixed production overheads based on the normal production capacity of our facilities. Inventory valuations were developed using normalized production capacities for each of our manufacturing locations. The costs from excess capacity or under-utilization of fixed production overheads were expensed in the period incurred and are not included as a component of inventory. Inventories also include tools, molds, and dies in progress that we are producing and will ultimately sell to our customers. These inventories are also carried at the lower of cost or net realizable value.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are stated at cost less accumulated depreciation. Assets to be disposed of are stated at the lower of depreciated cost or fair market value less estimated selling costs. Expenditures for maintenance and repairs are charged to expense as incurred. Major renewals and improvements are capitalized. When a property item is retired, its cost and related accumulated depreciation are removed from the property accounts and any gain or loss is recorded in the Consolidated Statements of Operations and Comprehensive Income (Loss). We review the carrying values of long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Property, plant and equipment also includes tools, molds, and dies used in manufacturing.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived tangible and intangible assets subject to depreciation or amortization are tested for recoverability when changes in circumstances indicate the carrying value of these assets, or asset groups, may not be recoverable. A test for recoverability is also performed when management has committed to a plan to dispose of a reporting unit or asset group. Assets to be held and used are tested for recoverability when indications of impairment are evident. Recoverability of a long-lived tangible or
Equity Method Investments	Equity Method Investments Our equity method investment is subject to a review for impairment if, and when, circumstances indicate that a decline in value below its carrying amount may have occurred. Examples of such circumstances include, but are not limited to, a significant deterioration in the earnings performance or business prospects of the investee; a significant adverse change in the regulatory, economic or technological environment of the investee; a significant adverse change in the general market condition of either the geographic area or the industry in which the investee operates; and recurring negative cash flows from operations. If management considers the decline to be other than temporary, we would write down the investment to its estimated fair market value.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Provision has been made for income taxes on unremitted earnings of certain foreign subsidiaries as these earnings are not deemed to be permanently reinvested. We recognize income tax positions that meet the more likely than not threshold and accrue interest and potential penalties related to unrecognized income tax positions which are recorded as a component of the provision (benefit) for income taxes. We treat global intangible low-taxed income (“GILTI”) as a periodic charge in the year in which it arises and therefore do not record deferred taxes for basis differences associated with GILTI. We eliminate disproportionate tax effects from accumulated other comprehensive income (loss) when the circumstances upon which they are premised cease to exist.
Revenue Recognition	Revenue Recognition We generally transfer control and recognize revenue when we ship the product from our manufacturing facility to our customer at a point in time, as this is when our customer obtains the ability to direct use of, and obtain substantially all of the remaining benefits from, the product. In limited circumstances, we recognize revenue over time as services are rendered. We have elected to recognize the cost for freight and shipping when control over products has transferred to the customer as a component of cost of sales. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost-plus-margin approach when an observable price is not available. The expected duration of our contracts is one year or less, and we have elected to apply the practical expedient that allows entities to disregard the effects of financing when the contract length is less than one year. The amount of consideration we receive and the revenue we recognize varies with volume rebates and incentives we offer to our customers. We estimate the amount of variable consideration that should be included in the transaction price utilizing the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. We utilize the portfolio approach practical expedient to evaluate sales-related discounts on a portfolio basis to contracts with similar characteristics. The effect on our consolidated financial statements of applying the portfolio approach would not differ materially from evaluation of individual contracts. We give our customers the right to return only defective products in exchange for functioning products or rework of the product. These transactions are evaluated and accounted for under ASC Topic 460, Guarantees
Share Based Compensation	Share Based CompensationThe cost of stock options, restricted stock, and performance share units is recognized as compensation expense over the vesting periods based on the grant date fair value, net of expected forfeitures.  We determine grant date fair value using the Black Scholes financial pricing model for stock options and a Monte Carlo simulation for performance share units that include a market condition for vesting because these awards are not traded in open markets. We determine grant date fair value using the closing price of our common stock on the date of grant for restricted stock and performance share units that include performance conditions for vesting.
Foreign Currency Translation	Foreign Currency Translation Assets and liabilities of our foreign subsidiaries are translated at current exchange rates. Revenue, costs, and expenses are translated at average rates prevailing during each reporting period. Translation adjustments arising from the translation of foreign subsidiary financial statements are reported as a component of other comprehensive income (loss) and accumulated other comprehensive income (loss) within stockholders’ equity. Transactions denominated in foreign currencies, including intercompany transactions, are initially recorded at the current exchange rate at the date of the transaction. The balances are adjusted to the current exchange rate as of each balance sheet date and as of the date when the transaction is consummated. Transaction gains or losses, excluding intercompany loan transactions, are expensed as incurred in either cost of sales or selling, general and administrative expense in the Consolidated Statements of Operations and Comprehensive Income (Loss) and were immaterial to the years ended December 31, 2022, 2021, and 2020. Transaction gains or losses on intercompany loan transactions are recognized as incurred in the “Other expense (income), net” line in the Consolidated Statements of Operations and Comprehensive Income (Loss). For the years ended December 31, 2022, 2021, and 2020, transaction gains (losses) on intercompany loan transactions were $0.2 million, $(0.5) million, and $(0.8) million, respectively.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share In accordance with ASC 260, Earnings Per Share, we allocate earnings or losses to common stockholders and participating securities using the two-class method to compute earnings per share (“EPS”) unless the treasury stock method results in a lower EPS. The two-class method is an earnings allocation formula that treats participating securities as having rights to earnings that otherwise would have been available to common stockholders. Participating securities may participate in undistributed earnings with common stock whether or not that participation is conditioned upon the occurrence of a specified event. Under the two-class method, our net income (loss) is reduced (or increased) by the amount that has been or will be distributed to our participating security holders. We have elected to allocate undistributed income to participating securities based on year-to-date results. Our participating securities, which include preferred stock, do not participate in losses. Basic net income (loss) per common share is computed by dividing net income (loss) allocable to common shares by the weighted average number of common shares outstanding. Diluted net income (loss) per common share includes the effect of warrants, convertible preferred stock, and stock options unless inclusion would not be dilutive.
Lessee, Leases	Leases We determine whether an arrangement is a lease at inception. Lease right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. When the implicit rate is not readily determinable, we use the estimated incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Amortization of lease ROU assets is recognized in expense on a straight-line basis over the lease term. We recognize short-term leases, which have a term of twelve months or less, on a straight-line basis and do not record a related lease asset or liability for such leases. Finance lease ROU assets consist primarily of equipment used in the manufacturing process with terms of four years to eight years. Operating lease ROU assets consist of the following: • Equipment used in the manufacturing process as well as office equipment with terms of two years to five years; and • Manufacturing plants and office facilities with terms of four years to 20 years.

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Summary of Discontinued Operations	The following table presents the results of operations of the discontinued operations. Years Ended December 31, 2021 2020 Net sales $ — $ 225,255 Cost of sales (exclusive of depreciation and amortization shown separately below) — 160,464 Selling, general, and administrative expense — 20,779 Depreciation and amortization — 35,731 Goodwill impairment — 146,757 Other operating expense, net — 41 Income from operations — (138,517) Interest expense — 48,893 Loss on extinguishment of debt and write-off of debt issuance costs — 1,388 Other expense, net — (322) Loss from discontinued operations before costs of disposal and benefit for income taxes — (188,476) Benefit for income taxes — 12,468 Loss from discontinued operations before costs of disposal — (176,008) Gain on disposal of discontinued operations 1,200 212,319 Benefit for income taxes on costs of disposal — 2,587 Income (loss) from discontinued operations, net of tax $ 1,200 $ 38,898 Years Ended December 31, 2021 2020 Interest on debt $ — $ 35,147 Amortization of debt issuance costs — 13,990 Capitalized interest and other — (244) Total interest expense of discontinued operations $ — $ 48,893 The following table presents the significant noncash items and cash paid for capital expenditures of discontinued operations for each period presented. Years Ended December 31, 2021 2020 Depreciation and amortization $ — $ 35,731 Goodwill impairment — 146,757 Amortization of debt issuance costs — 13,990 Loss on extinguishment of debt and write-off of debt issuance costs — 1,388 Acquisition of property, plant and equipment — 8,416 Right-of-use assets obtained in exchange for new finance lease liabilities — 695 Right-of-use assets obtained in exchange for new operating lease liabilities (1) — 6,174 _______________________________ (1) Includes new leases, renewals, and modifications.

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information	The following table presents our financial performance by reportable segment. Year Ended December 31, 2022 2021 2020 Net sales: Mobile Solutions $ 293,536 $ 285,863 $ 256,360 Power Solutions 205,204 191,800 171,269 Corporate and Consolidations (1) (2) (79) (95) Total $ 498,738 $ 477,584 $ 427,534 Income (loss) from operations: Mobile Solutions $ (2,165) $ 9,039 $ 5,228 Power Solutions 3,536 6,493 (85,983) Corporate and Consolidations (22,463) (24,536) (36,702) Total $ (21,092) $ (9,004) $ (117,457) Depreciation and amortization: Mobile Solutions $ 28,192 $ 28,769 $ 28,298 Power Solutions 17,483 15,892 15,730 Corporate and Consolidations 1,556 1,534 1,652 Total $ 47,231 $ 46,195 $ 45,680 Expenditures for long-lived assets: Mobile Solutions $ 14,590 $ 15,411 $ 12,400 Power Solutions 2,401 2,200 2,754 Corporate and Consolidations 961 610 203 Total $ 17,952 $ 18,221 $ 15,357 _______________________________ (1) Includes eliminations of intersegment transactions which occur during the ordinary course of business. The following table summarizes total assets by reportable segment. As of December 31, 2022 2021 Mobile Solutions (1) $ 338,338 $ 357,171 Power Solutions 178,129 184,196 Corporate and Consolidations 29,660 37,734 Total $ 546,127 $ 579,101 _______________________________ (1) Total assets in Mobile Solutions includes $31.8 million and $34.0 million as of December 31, 2022 and 2021, respectively, related to the investment in our 49% owned joint venture (Note 9).
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]	The following table summarizes long-lived tangible assets by country. As of December 31, 2022 2021 United States $ 104,360 $ 112,430 China 29,603 32,605 France 24,536 26,977 Mexico 15,235 12,056 Brazil 14,829 15,042 Poland 9,074 9,995 All foreign countries $ 93,277 $ 96,675 Total $ 197,637 $ 209,105

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Summary of Activity in the Allowance for Credit Losses	The following table presents changes in the allowance for credit losses. Years Ended December 31, 2022 2021 2020 Balance at beginning of year $ 1,352 $ 2,044 $ 2,044 Additions 326 78 505 Write-offs and other (182) (734) (562) Currency impact (27) (36) 57 Balance at end of year $ 1,469 $ 1,352 $ 2,044

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories are comprised of the following amounts: As of December 31, 2022 2021 Raw materials $ 32,146 $ 27,221 Work in process 24,610 24,960 Finished goods 23,926 22,846 Total inventories $ 80,682 $ 75,027

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment are comprised of the following amounts: As of December 31, 2022 2021 Land and buildings $ 58,256 $ 57,991 Machinery and equipment 353,364 344,041 Construction in progress 11,063 5,009 Total 422,683 407,041 Less: Accumulated depreciation 225,046 197,936 Property, plant and equipment, net $ 197,637 $ 209,105

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Carrying Amount of Intangible Assets by Segment and by Major Asset Class	The following table shows changes in the carrying amount of intangible assets, net, by reportable segment. Mobile Solutions Power Solutions Total Balance as of December 31, 2020 $ 29,062 $ 74,003 $ 103,065 Amortization (3,353) (10,994) (14,347) Balance as of December 31, 2021 25,709 63,009 88,718 Amortization (3,353) (12,474) (15,827) Balance as of December 31, 2022 $ 22,356 $ 50,535 $ 72,891 The following table shows the cost and accumulated amortization of our intangible assets as of December 31, 2022 and 2021. December 31, 2022 December 31, 2021 Gross Carrying Value as of Acquisition Date Accumulated Net Gross Carrying Value as of Acquisition Date Accumulated Net Customer relationships $ 173,746 $ (103,021) $ 70,725 $ 173,746 $ (87,895) $ 85,851 Trademark and trade name 7,527 (5,361) 2,166 7,527 (4,660) 2,867 Total identified intangible assets $ 181,273 $ (108,382) $ 72,891 $ 181,273 $ (92,555) $ 88,718
Summary of Estimated Amortization Expense	The following table shows estimated future amortization expense for each of the next five years. Year Ending December 31, 2023 $ 14,167 2024 13,824 2025 13,824 2026 13,824 2027 11,663

Investment in Joint Venture (Ta

Investment in Joint Venture (Tables)	12 Months Ended
	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Summarized Activity Related to Investment in Joint Venture	The following table shows changes in our investment in the JV. Balance as of December 31, 2021 $ 34,045 Share of earnings 6,592 Dividends paid by joint venture (6,245) Foreign currency translation loss (2,590) Balance as of December 31, 2022 $ 31,802 The following tables show summarized financial information of the unconsolidated JV. Year Ended December 31, 2022 2021 2020 Net sales 101,565 94,846 68,216 Cost of sales 84,654 77,620 56,669 Income from operations 15,111 15,429 10,202 Net income 13,453 12,777 7,401 December 31, 2022 2021 Current assets 63,141 65,465 Noncurrent assets 79,473 75,222 Current liabilities 66,960 67,206 Noncurrent liabilities 8,695 10,006

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Loss from Continuing Operations Before Benefit for Income Taxes	The following table summarizes the income (loss) from continuing operations before benefit (provision) for income taxes and share of net income from joint venture. Years Ended December 31, 2022 2021 2020 United States $ (40,543) $ (35,325) $ (146,963) Foreign 9,474 12,883 (5,125) Loss from continuing operations before benefit (provision) for income taxes and share of net income from joint venture $ (31,069) $ (22,442) $ (152,088)
Income Tax Expense (Benefit)	The following table summarizes total income tax expense (benefit) recognized in each year. Years Ended December 31, 2022 2021 2020 Current taxes: U.S. Federal $ (545) $ (19) $ (299) State (625) (615) 4,599 Foreign 4,576 3,014 2,250 Total current tax expense 3,406 2,380 6,550 Deferred taxes: U.S. Federal $ (6,245) $ (8,421) $ (10,368) State 70 (1,099) (5,368) Foreign (986) (154) (1,852) U.S. federal, state and foreign valuation allowance 5,376 5,538 2,066 Total deferred tax benefit (1,785) (4,136) (15,522) Total income tax expense (benefit) $ 1,621 $ (1,756) $ (8,972)
Reconciliation of Income Taxes Based on U.S. Federal Statutory Rate	The following table presents a reconciliation of income taxes based on the U.S. federal statutory income tax rate. Years Ended December 31, 2022 2021 2020 U.S federal statutory income tax rate 21.0 % 21.0 % 21.0 % Change in valuation allowance, exclusive of state (17.5) % (20.0) % (1.3) % State taxes, net of federal taxes, exclusive of tax reform 1.6 % 4.5 % 0.2 % Non-U.S. earnings taxed at different rates 0.7 % 3.0 % 1.4 % GILTI (3.9) % (6.0) % (0.1) % Goodwill impairment — % — % (12.7) % Deferred true-up (6.4) % — % — % Research and development tax credit 1.5 % 2.3 % 0.4 % Change in uncertain tax positions — % 0.7 % 2.2 % CARES Act — % — % 2.7 % Interest on CARES Act refund 1.8 % — % — % Return to provision 1.3 % 0.8 % (0.5) % Taxes on unremitted foreign earnings (3.9) % 2.0 % (3.9) % Restructuring gain — % — % (2.6) % Intercompany lending (2.7) % (5.3) % — % Warrant revaluation 3.6 % 6.5 % — % Other adjustments, net (2.3) % (1.7) % (0.9) % Effective tax rate (5.2) % 7.8 % 5.9 %
Principal Components of Deferred Tax Assets and Liabilities	The following table summarizes the principal components of the deferred tax assets and liabilities. As of December 31, 2022 2021 Deferred income tax liabilities: Tax in excess of book depreciation $ 24,045 $ 25,732 Intangible assets 16,978 20,812 Operating leases 10,669 10,473 Interest rate swap 754 37 Taxes on unremitted foreign earnings 4,961 5,630 Other deferred tax liabilities 761 1,007 Total deferred income tax liabilities 58,168 63,691 Deferred income tax assets: Interest expense limitation 10,723 7,141 Goodwill 22,277 24,262 Inventories 2,292 3,368 Section 174 research and development costs 1,859 — Pension and personnel accruals 1,717 2,422 Operating leases 12,852 12,834 Net operating loss carryforwards 24,299 23,629 Credit carryforwards 2,803 3,044 Accruals and reserves 978 1,435 Other deferred tax assets 3,086 4,223 Deferred income tax assets before valuation allowance 82,886 82,358 Valuation allowance on deferred tax assets (30,212) (25,809) Total deferred income tax assets 52,674 56,549 Net deferred income tax liabilities $ 5,494 $ 7,142
Summary of Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits, Excluding Interest and Penalties	The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits, excluding interest and penalties. Years Ended December 31, 2022 2021 2020 Balance at beginning of year $ 125 $ 247 $ 2,589 Additions for tax positions of prior years — — 121 Reductions for tax positions of prior years (7) (122) (2,463) Balance at end of year $ 118 $ 125 $ 247

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Summary of Debt	The following table presents the outstanding debt balances. As of December 31, 2022 2021 Term Loan Facility $ 147,375 $ 148,875 ABL Facility 1,000 — International loans 8,729 10,930 Total principal 157,104 159,805 Less-current maturities of long-term debt 3,321 3,074 Principal, net of current portion 153,783 156,731 Less-unamortized debt issuance costs and discount (1) 4,394 5,679 Long-term debt, net of current portion $ 149,389 $ 151,052 _______________________________ (1) In addition to this amount, costs of $0.6 million and $0.7 million related to the ABL Facility were recorded in other non-current assets as of December 31, 2022 and 2021, respectively.
Aggregate Maturities of Long-Term Debt	The following table lists aggregate maturities of long-term debt for the next five years. Years Ending December 31, 2023 $ 3,321 2024 3,166 2025 3,181 2026 143,887 2027 364

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Lease, Cost	The following table presents components of lease expense: Years Ended December 31, 2022 2021 2020 Finance lease cost: Amortization of right-of-use assets $ 1,318 $ 1,451 $ 1,272 Interest expense 351 213 192 Operating lease cost 8,285 8,015 8,397 Short-term lease cost (1) 438 655 591 Sublease income (195) — — Total lease cost $ 10,197 $ 10,334 $ 10,452 _______________________________ (1) Excludes expenses related to leases with a lease term of one month or less. The following table contains supplemental cash flow information related to leases. Years Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used in finance leases $ 351 $ 213 $ 192 Operating cash flows used in operating leases 14,214 13,434 13,498 Financing cash flows used in finance leases 3,003 4,836 2,018 Right-of-use assets obtained in exchange for new finance lease liabilities $ 1,263 $ 2,814 $ 728 Right-of-use assets obtained in exchange for new operating lease liabilities (1) 5,181 — 8,682 _______________________________ (1) Includes new leases, renewals, and modifications. The weighted average remaining lease term and weighted-average discount rate for finance and operating leases were as follows: As of December 31, 2022 2021 Weighted-average remaining lease term - finance leases 3.1 years 3.3 years Weighted-average remaining lease term - operating leases 10.1 years 11.1 years Weighted-average discount rate - finance leases 5.3 % 3.0 % Weighted-average discount rate - operating leases 7.5 % 7.0 %
Assets And Liabilities, Lessee	The following table presents lease-related assets and liabilities recorded on the balance sheet. As of December 31, Financial Statement Line Item 2022 2021 Assets: Operating lease assets Operating lease right-of-use assets $ 46,713 $ 46,443 Finance lease assets Property, plant and equipment, net 12,989 13,641 Total lease assets $ 59,702 $ 60,084 Liabilities: Current liabilities: Operating lease liabilities Current portion of operating lease liabilities $ 5,294 $ 5,704 Finance lease liabilities Other current liabilities 2,610 3,111 Non-current liabilities: Operating lease liabilities Operating lease liabilities, net of current portion 51,411 51,295 Finance lease liabilities Other non-current liabilities 3,828 5,446 Total lease liabilities $ 63,143 $ 65,556
Lessee, Operating Lease, Liability, Maturity	The maturities of lease liabilities as of December 31, 2022, is as follows: Operating Leases Finance Leases 2023 $ 9,250 $ 2,913 2024 8,419 1,819 2025 8,352 1,017 2026 8,193 950 2027 7,983 509 Thereafter 37,655 — Total future minimum lease payments 79,852 7,208 Less: imputed interest 23,147 770 Total lease liabilities $ 56,705 $ 6,438
Finance Lease, Liability, Maturity	The maturities of lease liabilities as of December 31, 2022, is as follows: Operating Leases Finance Leases 2023 $ 9,250 $ 2,913 2024 8,419 1,819 2025 8,352 1,017 2026 8,193 950 2027 7,983 509 Thereafter 37,655 — Total future minimum lease payments 79,852 7,208 Less: imputed interest 23,147 770 Total lease liabilities $ 56,705 $ 6,438

Preferred Stock and Stockhold_2

Preferred Stock and Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Changes In Preferred Stock Carrying Value	The following table presents the change in the Series D Preferred Stock carrying value. Years Ended December 31, 2022 2021 Balance at beginning of year $ 53,807 $ — Proceeds from issuance of shares, net of issuance costs — 61,793 Fair value of 2021 Warrants issued — (14,839) Recognition of bifurcated embedded derivative — (282) Accrual of in-kind dividends 8,961 6,222 Amortization 1,933 913 Balance at end of year $ 64,701 $ 53,807 Years Ended December 31, 2021 2020 Balance at beginning of year $ 105,086 $ 93,012 Accrual of in-kind dividends 14,008 11,121 Amortization 335 953 Redemption (119,429) — Balance at end of year $ — $ 105,086

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments	Year Ended December 31, 2022 Mobile Power Intersegment Total United States and Puerto Rico $ 140,931 $ 160,894 $ (2) $ 301,823 China 46,045 5,511 — 51,556 Brazil 47,266 950 — 48,216 Mexico 23,348 17,297 — 40,645 Germany 5,158 348 — 5,506 Poland 5,031 11 — 5,042 Other 25,757 20,193 — 45,950 Total net sales $ 293,536 $ 205,204 $ (2) $ 498,738 Year Ended December 31, 2021 Mobile Power Intersegment Total United States and Puerto Rico $ 140,383 $ 152,931 $ (79) $ 293,235 China 52,227 4,745 — 56,972 Brazil 34,644 811 — 35,455 Mexico 19,520 16,177 — 35,697 Germany 5,230 546 — 5,776 Poland 3,743 18 — 3,761 Other 30,116 16,572 — 46,688 Total net sales $ 285,863 $ 191,800 $ (79) $ 477,584 Year Ended December 31, 2020 Mobile Power Intersegment Total United States and Puerto Rico $ 129,147 $ 139,499 $ (95) $ 268,551 China 46,442 5,563 — 52,005 Brazil 27,055 689 — 27,744 Mexico 16,465 13,400 — 29,865 Germany 5,846 378 — 6,224 Poland 4,913 14 — 4,927 Other 26,492 11,726 — 38,218 Total net sales $ 256,360 $ 171,269 $ (95) $ 427,534
Disaggregation of Revenue	Year Ended December 31, 2022 Mobile Power Intersegment Total Automotive $ 197,341 $ 40,890 $ — $ 238,231 General Industrial 78,142 61,828 — 139,970 Residential/Commercial Electrical — 70,055 — 70,055 Other 18,053 32,431 (2) 50,482 Total net sales $ 293,536 $ 205,204 $ (2) $ 498,738 Year Ended December 31, 2021 Mobile Power Intersegment Total Automotive $ 182,094 $ 38,779 $ — $ 220,873 General Industrial 90,290 60,312 — 150,602 Residential/Commercial Electrical — 61,748 — 61,748 Other 13,479 30,961 (79) 44,361 Total net sales $ 285,863 $ 191,800 $ (79) $ 477,584 Year Ended December 31, 2020 Mobile Power Intersegment Total Automotive $ 170,389 $ 31,422 $ — $ 201,811 General Industrial 75,610 52,714 — 128,324 Residential/Commercial Electrical — 58,143 — 58,143 Other 10,361 28,990 (95) 39,256 Total net sales $ 256,360 $ 171,269 $ (95) $ 427,534

Share-Based Compensation (Table

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Components of Share-Based Compensation Expense by Type of Award	The following table lists the components of share-based compensation expense by type of award. Years Ended December 31, 2022 2021 2020 Restricted stock 3,635 2,166 3,393 Performance share units 602 797 199 Stock options $ 140 $ 253 $ 634 Share-based compensation expense $ 4,377 $ 3,216 $ 4,226
Reconciliation of Restricted Stock Option Activity	The following table presents the status of unvested restricted stock awards as of December 31, 2022 and changes during the year then ended. Nonvested Weighted Average Grant-Date Unvested at January 1, 2022 469,000 $ 7.28 Granted 897,000 3.31 Vested (291,000) 7.05 Forfeited (37,000) 3.93 Unvested at December 31, 2022 1,038,000 $ 4.03
Schedule of Performance Based Awards Goals with Respect to TSR and ROIC	The following tables present the goals with respect to TSR Awards and ROIC Awards granted in 2022, 2021, and 2020. TSR Awards: Threshold Performance (25% or 50% of Shares) (1) Target Performance Maximum Performance 2022 grants 25 th Percentile 55 th Percentile 75 th Percentile 2021 grants 35 th Percentile 50 th Percentile 75 th Percentile 2020 grants 35 th Percentile 50 th Percentile 75 th Percentile ROIC Awards: Threshold Performance Target Performance Maximum Performance 2022 grants 6.4 % 8.6 % 10.0 % 2021 grants 6.3 % 7.0 % 8.6 % 2020 grants 6.7 % 7.9 % 8.7 % _______________________________
Schedule of Number of Awards Granted and Grant Date Fair Value of Each Award in Periods	The following table presents the number of PSUs granted and the grant-date fair value of each award in the periods presented. TSR Awards ROIC Awards Award Year Performance Units Grant-Date Performance Units Grant-Date 2022 382,000 $ 2.53 408,000 $ 2.62 2021 142,000 $ 8.58 172,000 $ 7.20 2020 139,000 $ 10.88 157,000 $ 9.44
Summary of Status of Unvested PSU Awards	The following table presents the status of unvested PSUs as of December 31, 2022 and changes during the year then ended. Nonvested TSR Awards Nonvested ROIC Awards Number of Performance Units Weighted Average Grant-Date Number of Performance Units Weighted Average Grant-Date Nonvested at January 1, 2022 194,000 $ 9.59 228,000 $ 8.14 Granted 382,000 2.53 408,000 2.62 Expired (84,000) 10.88 (96,000) 9.44 Nonvested at December 31, 2022 492,000 $ 3.87 540,000 $ 3.74

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive income (loss) (“AOCI”) are as follows: Foreign Currency Translation Interest rate swap Income taxes (1) Total Balance as of December 31, 2019 $ (35,159) $ (12,234) $ 2,839 $ (44,554) Other comprehensive income (loss) before reclassifications (1,683) (16,207) 3,764 (14,126) Amounts reclassified from AOCI to interest expense (2) — 8,906 (2,068) 6,838 Amounts reclassified from AOCI to loss on interest rate swap (3) — 15,823 (3,674) 12,149 Sale of discontinued operations 5,961 — — 5,961 Net other comprehensive income (loss) 4,278 8,522 (1,978) 10,822 Balance as of December 31, 2020 $ (30,881) $ (3,712) $ 861 $ (33,732) Other comprehensive income (loss) before reclassifications (1,135) 78 (19) (1,076) Amounts reclassified from AOCI to interest expense (2) — 73 (18) 55 Amounts reclassified from AOCI to loss on interest rate swap (3) — 3,712 (861) 2,851 Net other comprehensive income (loss) (1,135) 3,863 (898) 1,830 Balance as of December 31, 2021 $ (32,016) $ 151 $ (37) $ (31,902) Other comprehensive income (loss) before reclassifications (8,156) 3,426 (68) (4,798) Amounts reclassified from AOCI to interest expense (2) — (428) 8 (420) Net other comprehensive income (loss) (8,156) 2,998 (60) (5,218) Balance as of December 31, 2022 $ (40,172) $ 3,149 $ (97) $ (37,120) _______________________________ (1) Income tax effect of changes in interest rate swap. (2) Represents interest rate swap settlements of effective hedge. (3) Represents reclassification of derivative loss and settlements after discontinuation of hedge accounting. See Note 19 for further discussion of the interest rate swap.

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Summary of Net Income (Loss) Per Share	The following table summarizes the computation of basic and diluted net income (loss) per common share. Years Ended December 31, 2022 2021 2020 Numerator: Loss from continuing operations $ (26,098) $ (14,425) $ (139,490) Adjustment for preferred stock cumulative dividends and deemed dividends (10,894) (21,478) (12,373) Numerator for basic and diluted net loss from continuing operations per common share (36,992) (35,903) (151,863) Income from discontinued operations, net of tax — 1,200 38,898 Numerator for basic and diluted net loss per common share $ (36,992) $ (34,703) $ (112,965) Denominator: Weighted average common shares outstanding 43,738 42,991 42,692 Adjustment for participating securities (951) (461) (493) Adjustment for 2021 Warrants outstanding (1) 1,893 1,481 — Shares used to calculate basic and diluted net loss per share 44,680 44,011 42,199 Per common share net income (loss): Basic and diluted net loss from continuing operations per common share $ (0.83) $ (0.82) $ (3.60) Basic and diluted net income from discontinued operations per common share — 0.03 0.92 Basic and diluted net loss per common share $ (0.83) $ (0.79) $ (2.68) Cash dividends declared per common share $ — $ — $ — _______________________________ (1) Weighted average 2021 Warrants outstanding are included in shares outstanding for calculation of basic earnings per share because they are exercisable at an exercise price of $0.01 per share, subject to certain adjustments (see Note 19).
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table presents potentially dilutive securities that were excluded from the calculation of diluted net income (loss) per common share because they had an anti-dilutive effect. Years Ended December 31, 2022 2021 2020 Options 557 766 871 2019 Warrants 1,500 1,500 1,500 Series B Preferred Stock, as-converted — — 19,021 2,057 2,266 21,392

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Derivative Instruments	The following tables show the fair values of the preferred stock related derivatives within the fair value hierarchy. December 31, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative liability - other non-current liabilities 2,831 — 128 December 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative liability - other non-current liabilities 7,771 — 453 The fair value of the 2019 Warrants is determined using a valuation model that utilizes unobservable inputs to determine the probability that the 2019 Warrants will remain outstanding for future periods. The probabilities resulted in a weighted average term of 2.9 years as of December 31, 2022 and 3.6 years as of December 31, 2021.
Schedule of Effect of Interest Rate Swaps	Years Ended December 31, 2022 2021 2020 Interest expense (benefit) (1) $ (428) $ 73 $ 8,906 Derivative payments on interest rate swap (2) — 1,717 4,133 Loss on interest rate swap (2) — 2,033 11,669
Schedule of Fair Value Of Liabilities On a Recurring Basis	December 31, 2022 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative asset - other current assets $ — $ 2,130 $ — Derivative asset - other non-current assets — 1,023 — Total $ — $ 3,153 $ — December 31, 2021 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Derivative asset - other non-current assets $ — $ 284 $ — Derivative liability - other current liabilities — (129) — Total $ — $ 155 $ —

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Detail) $ in Thousands		12 Months Ended
	Oct. 06, 2020 USD ($)	Dec. 31, 2022 USD ($) manufacturing_facility	Dec. 31, 2021 USD ($)		Dec. 31, 2020 USD ($)		Dec. 31, 2019 USD ($)	[1]
Significant Accounting Policies [Line Items]
Number of manufacturing facilities | manufacturing_facility		31
Proceeds from sale of business		$ 0	$ (3,880)		$ 743,178
Gains (losses) on intercompany loan transactions		200	(500)		(800)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		12,808	28,656	[1]	$ 48,138	[1]	$ 31,703
Cash Grants Amounts		1,400
Geographic Distribution, Foreign
Significant Accounting Policies [Line Items]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		$ 12,500	$ 17,600
Senior Secured And Incremental Term Loans
Significant Accounting Policies [Line Items]
Repayments of debt	$ 700,000
Life Sciences | Discontinued Operations, Disposed of by Sale
Significant Accounting Policies [Line Items]
Proceeds from sale of business	$ 757,200
Land and buildings | Minimum
Significant Accounting Policies [Line Items]
Estimated useful lives		10 years
Land and buildings | Maximum
Significant Accounting Policies [Line Items]
Estimated useful lives		40 years
Machinery and equipment | Minimum
Significant Accounting Policies [Line Items]
Estimated useful lives		3 years
Machinery and equipment | Maximum
Significant Accounting Policies [Line Items]
Estimated useful lives		12 years
Wuxi Weifu Autocam Precision Machinery Company, Ltd.
Significant Accounting Policies [Line Items]
Investment in joint venture		49%
[1]Cash and cash equivalents include $13.8 million of cash and cash equivalents that were included in current assets of discontinued operations as of December 31, 2019.

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended	12 Months Ended
	Oct. 06, 2020	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Aug. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of business			$ 0	$ (3,880)	$ 743,178
Gain on sale of discontinued operations, net of tax			0	1,200	233,824
Goodwill impairment of continuing operations			0	0	$ 92,942
Life Sciences
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Goodwill impairment of continuing operations		$ 146,800
Senior Secured And Incremental Term Loans
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Repayments of debt	$ 700,000
Discontinued Operations, Disposed of by Sale | Life Sciences
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate purchase price of the stock purchase plan			753,300
Potential earnout payment						$ 70,000
Proceeds from sale of business	$ 757,200
Disposal group payables			3,900
Estimated tax indemnification			$ 0	$ 1,200

Discontinued Operations - Summa

Discontinued Operations - Summary of Major Line Items Included in Results of Operations of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operations, Goodwill, Impairment Loss	$ 0	$ 0	$ 146,757
Income (loss) from discontinued operations, net of tax	$ 0	1,200	38,898
Discontinued Operations, Disposed of by Sale | Life Sciences
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Revenue		0	225,255
Disposal Group, Including Discontinued Operation, Costs of Goods Sold		0	160,464
Disposal Group, Including Discontinued Operation, General and Administrative Expense		0	20,779
Disposal Group, Including Discontinued Operation, Depreciation and Amortization		0	35,731
Disposal Group, Including Discontinued Operations, Goodwill, Impairment Loss		0	146,757
Other operating expense, net		0	41
Disposal Group, Including Discontinued Operation, Operating Income (Loss)		0	(138,517)
Disposal Group, Including Discontinued Operation, Interest Expense		0	48,893
Disposal Group, Including Discontinued Operations, Gain (Loss) On Extinguishment Of Debt		0	1,388
Disposal Group, Including Discontinued Operations, Other Nonoperating Income (Expense), Net		0	(322)
Loss from discontinued operations before costs of disposal and benefit for income taxes		0	(188,476)
Benefit for income taxes		0	12,468
Loss from discontinued operations before costs of disposal		0	(176,008)
Gain on disposal of discontinued operations		1,200	212,319
Benefit for income taxes on costs of disposal		0	2,587
Income (loss) from discontinued operations, net of tax		$ 1,200	$ 38,898

Discontinued Operations - Inter

Discontinued Operations - Interest Expense Reclassified to Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Amortization of debt issuance costs and discount	$ 1,361	$ 1,381	$ 15,692
Interest expense	$ 15,041	12,664	18,898
Life Sciences | Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Interest Expense, Debt		0	35,147
Amortization of debt issuance costs and discount		0	13,990
Interest Costs Capitalized Adjustment		0	(244)
Interest expense		$ 0	$ 48,893

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Significant Noncash Items and Cash Paid for Capital Expenditures of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and Amortization, Discontinued Operations	$ 0	$ 0	$ 35,731
Disposal Group, Including Discontinued Operations, Goodwill, Impairment Loss	0	0	146,757
Amortization of debt issuance costs and discount	$ 1,361	1,381	15,692
Discontinued Operations, Disposed of by Sale | Life Sciences
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and Amortization, Discontinued Operations		0	35,731
Disposal Group, Including Discontinued Operations, Goodwill, Impairment Loss		0	146,757
Amortization of debt issuance costs and discount		0	13,990
Disposal Group, Including Discontinued Operations, Gain (Loss) On Extinguishment Of Debt		0	1,388
Capital Expenditure, Discontinued Operations		0	8,416
Right Of Use Asset Obtained In Exchange For Finance Lease Liability, Discontinued Operations		0	695
Right-of-use assets obtained in exchange for new operating lease liabilities		$ 0	$ 6,174

Segment Information - (Detail)

Segment Information - (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Segment Reporting Information [Line Items]
Net sales	$ 498,738	$ 477,584	$ 427,534
Operating Income (Loss)	(21,092)	(9,004)	(117,457)
Depreciation and amortization	47,231	46,195	45,680
Expenditures for long-lived assets	17,952	18,221	23,773
Assets	546,127	579,101
Investment in joint venture	$ 31,802	34,045
Operating segments | segment	2
Continuing Operations
Segment Reporting Information [Line Items]
Expenditures for long-lived assets			15,357
United States
Segment Reporting Information [Line Items]
Net sales	$ 301,823	293,235	268,551
Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Net sales	(2)	(79)	(95)
Assets	29,660	37,734
Intersegment Eliminations [Member] | United States
Segment Reporting Information [Line Items]
Net sales	(2)	(79)	(95)
Mobile Solutions | Operating Segments
Segment Reporting Information [Line Items]
Net sales	293,536	285,863	256,360
Operating Income (Loss)	(2,165)	9,039	5,228
Depreciation and amortization	28,192	28,769	28,298
Expenditures for long-lived assets	14,590	15,411	12,400
Assets	338,338	357,171
Mobile Solutions | Operating Segments | United States
Segment Reporting Information [Line Items]
Net sales	140,931	140,383	129,147
Power Solutions | Operating Segments
Segment Reporting Information [Line Items]
Net sales	205,204	191,800	171,269
Operating Income (Loss)	3,536	6,493	(85,983)
Depreciation and amortization	17,483	15,892	15,730
Expenditures for long-lived assets	2,401	2,200	2,754
Assets	178,129	184,196
Power Solutions | Operating Segments | United States
Segment Reporting Information [Line Items]
Net sales	160,894	152,931	139,499
Corporate And Eliminations | Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	(22,463)	(24,536)	(36,702)
Depreciation and amortization	1,556	1,534	1,652
Expenditures for long-lived assets	$ 961	$ 610	$ 203

Long Lived Assets by Country (D

Long Lived Assets by Country (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 197,637	$ 209,105
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	104,360	112,430
CHINA
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	29,603	32,605
FRANCE
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	24,536	26,977
Mexico
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	15,235	12,056
BRAZIL
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	14,829	15,042
POLAND
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	9,074	9,995
Geographic Distribution, Foreign
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 93,277	$ 96,675

Accounts Receivable - Summary o

Accounts Receivable - Summary of Activity in the Allowance for Credit Losses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	$ 1,352	$ 2,044	$ 2,044
Additions	326	78	505
Write-offs and other	(182)	(734)	(562)
Currency impact	(27)	(36)	57
Balance at end of year	$ 1,469	$ 1,352	$ 2,044

Accounts Receivable - Additiona

Accounts Receivable - Additional Information (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Gain (Loss) on Securitization of Financial Assets	$ 0.6

Inventories - Summary of Invent

Inventories - Summary of Inventories (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 32,146	$ 27,221
Work in process	24,610	24,960
Finished goods	23,926	22,846
Total inventories	$ 80,682	$ 75,027

Property, Plant and Equipment -

Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 422,683	$ 407,041
Less: Accumulated depreciation	225,046	197,936
Property, plant and equipment, net	197,637	209,105
Land and buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	58,256	57,991
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	353,364	344,041
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 11,063	$ 5,009

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Impairment charges			$ 4,100
Depreciation expense	$ 31,400	$ 31,800	$ 31,300

Goodwill - Additional Informati

Goodwill - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Line Items]
Goodwill	$ 0
Goodwill impairment of continuing operations	$ 0	$ 0	$ 92,942

Intangible Assets, Net - Summar

Intangible Assets, Net - Summary of Carrying Amount of Intangible Assets by Segment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Beginning balance	$ 88,718	$ 103,065
Amortization of Intangible Assets	(15,827)	(14,347)
Ending balance	72,891	88,718
Mobile Solutions
Finite-Lived Intangible Assets [Line Items]
Beginning balance	25,709	29,062
Amortization of Intangible Assets	(3,353)	(3,353)
Ending balance	22,356	25,709
Power Solutions
Finite-Lived Intangible Assets [Line Items]
Beginning balance	63,009	74,003
Amortization of Intangible Assets	(12,474)	(10,994)
Ending balance	$ 50,535	$ 63,009

Intangible Assets, Net - Summ_2

Intangible Assets, Net - Summary of Carrying Amount of Intangible Assets by Major Asset Class (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value as of Acquisition Date	$ 181,273	$ 181,273
Accumulated Amortization	(108,382)	(92,555)
Net Carrying Value	72,891	88,718	$ 103,065
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value as of Acquisition Date	173,746	173,746
Accumulated Amortization	(103,021)	(87,895)
Net Carrying Value	70,725	85,851
Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value as of Acquisition Date	7,527	7,527
Accumulated Amortization	(5,361)	(4,660)
Net Carrying Value	$ 2,166	$ 2,867

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Finite Lived Intangible Assets Future Amortization Expense Table (Detail) $ in Thousands	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 14,167
2024	13,824
2025	13,824
2026	13,824
2027	$ 11,663

Investment in Joint Venture - A

Investment in Joint Venture - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Wuxi Weifu Autocam Precision Machinery Company, Ltd.
Schedule of Equity Method Investments [Line Items]
Revenues	$ 101,565	$ 94,846	$ 68,216
Amount due from joint venture	100
Revenue from Related Parties	$ 100	$ 400	$ 100
Wuxi Weifu Autocam Precision Machinery Company, Ltd.
Schedule of Equity Method Investments [Line Items]
Investment in joint venture	49%

Investment in Joint Venture - S

Investment in Joint Venture - Summarized Activity Related to Investment in Joint Venture (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Beginning Balance	$ 34,045
Ending Balance	31,802	$ 34,045
Share of earnings	6,592	6,261	$ 3,626
Joint Venture
Schedule of Equity Method Investments [Line Items]
Beginning Balance	34,045
Share of earnings	(6,245)
Foreign currency translation loss	(2,590)
Ending Balance	31,802	$ 34,045
Share of earnings	$ 6,592

Summarized Financial Informatio

Summarized Financial Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Operating Income (Loss)	$ (21,092)	$ (9,004)	$ (117,457)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(26,098)	(13,225)	(100,592)
Assets, Current	191,700	196,282
Liabilities, Current	78,806	74,017
Wuxi Weifu Autocam Precision Machinery Company, Ltd.
Schedule of Equity Method Investments [Line Items]
Revenues	101,565	94,846	68,216
Cost of Revenue	84,654	77,620	56,669
Operating Income (Loss)	15,111	15,429	10,202
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	13,453	12,777	$ 7,401
Assets, Current	63,141	65,465
Assets, Noncurrent	79,473	75,222
Liabilities, Current	66,960	67,206
Liabilities, Noncurrent	$ 8,695	$ 10,006

Income Taxes - Loss from Contin

Income Taxes - Loss from Continuing Operations Before Benefit for Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
Income (Loss) from Continuing Operations before Income Taxes, Domestic	$ (40,543)	$ (35,325)	$ (146,963)
Income (Loss) from Continuing Operations before Income Taxes, Foreign	9,474	12,883	(5,125)
Loss from continuing operations before benefit (provision) for income taxes and share of net income from joint venture	$ (31,069)	$ (22,442)	$ (152,088)

Income Taxes - Income Tax Expen

Income Taxes - Income Tax Expense (Benefit) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current Federal Tax Expense (Benefit)	$ (545)	$ (19)	$ (299)
Current State and Local Tax Expense (Benefit)	(625)	(615)	4,599
Current Foreign Tax Expense (Benefit)	4,576	3,014	2,250
Current Income Tax Expense (Benefit)	3,406	2,380	6,550
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Deferred Federal Income Tax Expense (Benefit)	(6,245)	(8,421)	(10,368)
Deferred State and Local Income Tax Expense (Benefit)	70	(1,099)	(5,368)
Deferred Foreign Income Tax Expense (Benefit)	(986)	(154)	(1,852)
Deferred Federal and Foreign Income Tax Expense (Benefit) Valuation Allowance	(5,376)	(5,538)	(2,066)
Deferred Income Tax Expense (Benefit), Total	(1,785)	(4,136)	(15,522)
Benefit (provision) for income taxes	$ 1,621	$ (1,756)	$ (8,972)

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Income Taxes Based on U.S. Federal Statutory Rate (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Federal corporate income tax rate	21%	21%	21%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	(17.50%)	(20.00%)	(1.30%)
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	1.60%	4.50%	0.20%
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	0.70%	3%	1.40%
Effective Income Tax Rate Reconciliation, GILTI, Percent	(3.90%)	(6.00%)	(0.10%)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent	0%	0%	(12.70%)
Effective Income Tax Rate Reconciliation, Deferred True Up, Percent	(6.40%)	0%	0%
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent	1.50%	2.30%	0.40%
Effective Income Tax Rate Reconciliation, Tax Contingency, Percent	0%	0.70%	2.20%
Effective Income Tax Rate Reconciliation, CARES Act	0%	0%	2.70%
Interest on CARES Act refund	1.80%	0%	0%
Effective Income Tax Rate Reconciliation, Return to Provision	1.30%	0.80%	(0.50%)
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent	(3.90%)	2%	(3.90%)
Effective Income Tax Rate Reconciliation, Intercompany Lending, Percent	(2.70%)	(5.30%)	0%
Warrant revaluation	3.60%	6.50%	0%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent	0%	0%	(2.60%)
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent	(2.30%)	(1.70%)	(0.90%)
Effective Income Tax Rate Reconciliation, Percent, Total	(5.20%)	7.80%	5.90%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Line Items]
Effective tax rate on non deductible expense	(5.20%)	7.80%	5.90%
Federal corporate income tax rate	21%	21%	21%
Valuation allowance on deferred tax assets	$ 30,212	$ 25,809
Deferred tax asset valuation allowance change in amount net	(4,400)
Deferred tax liability. repatriation of the unremitted earnings	5,000
Income tax examination, penalties and interest accrued	500	500	$ 600
Amount of unrecognized tax benefits would, if recognized, impact effective tax rate	600
Impact of these tax holidays decreased foreign taxes		$ 200	$ 200
Tax Benefit, Permanent Reinvestment Change	2,400
Income Tax Refund Interest Income	600
Foreign Tax Authority
Income Taxes [Line Items]
NOL carryovers	4,800
Operating loss carryforward, valuation allowance	1,800
Tax credits	2,600
Tax credit carryforward, valuation allowance	1,900
State and Local Jurisdiction
Income Taxes [Line Items]
NOL carryovers	239,500
Operating loss carryforward, valuation allowance	15,800
Tax credit carryforward, valuation allowance	2,100
Domestic Tax Authority
Income Taxes [Line Items]
NOL carryovers	33,400
Operating loss carryforward, valuation allowance	4,400
Tax credits	200
Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory	$ 8,000

Income Taxes - Principal Compon

Income Taxes - Principal Components of Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred Tax Liabilities, Net [Abstract]
Deferred Tax Liabilities, Property, Plant and Equipment	$ 24,045	$ 25,732
Deferred Tax Liabilities, Intangible Assets	16,978	20,812
Deferred Tax Liabilities, Leasing Arrangements	10,669	10,473
Deferred Tax Liabilities, Derivatives	754	37
Deferred Tax Liabilities, Undistributed Foreign Earnings	4,961	5,630
Deferred Tax Liabilities, Other	761	1,007
Deferred Tax Liabilities, Gross, Total	58,168	63,691
Components of Deferred Tax Assets [Abstract]
Deferred Tax Asset, Interest Expense Limitation	10,723	7,141
Deferred Tax Assets, Goodwill and Intangible Assets	22,277	24,262
Deferred Tax Assets, Inventory	2,292	3,368
Deferred Tax Assets, in Process Research and Development	1,859	0
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions	1,717	2,422
Deferred Tax Asset, Operating Lease, Right-Of-Use Assets	12,852	12,834
Deferred Tax Assets, Operating Loss Carryforwards	24,299	23,629
Deferred Tax Assets, Tax Credit Carryforwards	2,803	3,044
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves	978	1,435
Deferred Tax Assets, Other	3,086	4,223
Deferred Tax Assets, Gross, Total	82,886	82,358
Deferred Tax Assets, Valuation Allowance	(30,212)	(25,809)
Deferred Tax Assets, Net of Valuation Allowance, Total	52,674	56,549
Deferred Tax Liabilities, Net, Total	$ 5,494	$ 7,142

Income Taxes - Summary of Recon

Income Taxes - Summary of Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits, Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized Tax Benefits, Beginning Balance	$ 125	$ 247	$ 2,589
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions	0	0	121
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	(7)	(122)	(2,463)
Unrecognized Tax Benefits, Ending Balance	$ 118	$ 125	$ 247

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands		12 Months Ended
	Oct. 06, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Line of Credit Facility [Line Items]
Capitalized interest costs		$ (600)	$ (300)	$ (200)
Proceeds from sale of business		0	(3,880)	743,178
Loss on extinguishment of debt and write-off of debt issuance costs		0	2,390	1,532
Current maturities of long-term debt		3,321	3,074
Payments for Hedge, Investing Activities		0	15,420	4,133
Debt issuance costs, line of credit arrangements, net		600	700
Loss on extinguishment of debt and write-off of debt issuance costs		0	2,390	$ 144
Life Sciences | Discontinued Operations, Disposed of by Sale
Line of Credit Facility [Line Items]
Proceeds from sale of business	$ 757,200
Senior Secured Revolver
Line of Credit Facility [Line Items]
Senior debt		1,000	0
Outstanding letters of credit		11,000
Available borrowing capacity		35,300
Senior Secured And Incremental Term Loans
Line of Credit Facility [Line Items]
Repayments of debt	$ 700,000
Term Loan Facility Member
Line of Credit Facility [Line Items]
Debt instrument, face amount		$ 150,000
Interest rate during period		11.259%
Senior debt		$ 147,375	$ 148,875
Debt issuance costs		2,800
Debt Instrument, Periodic Payment, Principal		400
Debt Instrument, Unamortized Discount (Premium), Net		$ 3,800
Term Loan Facility Member | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Basis spread on variable rate		6.875%
Term Loan Facility Member | London Interbank Offered Rate (LIBOR) | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate		1%
Term Loan Facility Member | Various Benchmark Rates Member
Line of Credit Facility [Line Items]
Basis spread on variable rate		5.875%
Asset Backed Credit Facility Member
Line of Credit Facility [Line Items]
Line of credit face amount		$ 50,000
Interest rate during period		6%
Commitment fee percentage		0.375%
Asset Backed Credit Facility Member | Minimum
Line of Credit Facility [Line Items]
Debt Instrument LIBOR Floor Rate		0.50%
Asset Backed Credit Facility Member | London Interbank Offered Rate (LIBOR)
Line of Credit Facility [Line Items]
Basis spread on variable rate		1.75%
Asset Backed Credit Facility Member | London Interbank Offered Rate (LIBOR) | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate		1.75%
Asset Backed Credit Facility Member | London Interbank Offered Rate (LIBOR) | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate		2%
Asset Backed Credit Facility Member | Federal Funds Or Prime Rate Member | Minimum
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.75%
Asset Backed Credit Facility Member | Federal Funds Or Prime Rate Member | Maximum
Line of Credit Facility [Line Items]
Basis spread on variable rate		1%
Letter of Credit
Line of Credit Facility [Line Items]
Line of credit face amount		$ 30,000
Commitment fee percentage		1.875%
Bridge Loan
Line of Credit Facility [Line Items]
Line of credit face amount		$ 5,000

Debt - Summary of Debt (Detail)

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Total principal	$ 157,104	$ 159,805
Less-current maturities of long-term debt	3,321	3,074
Principal, net of current portion	153,783	156,731
Less-unamortized debt issuance costs	4,394	5,679
Long-term debt, net of current portion	149,389	151,052
Debt issuance costs, line of credit arrangements, net	600	700
Term Loan Facility Member
Debt Instrument [Line Items]
Senior debt	147,375	148,875
Foreign Line of Credit
Debt Instrument [Line Items]
Long-term Line of Credit	$ 8,729	$ 10,930

Debt - Aggregate Maturities of

Debt - Aggregate Maturities of Long-Term Debt (Detail) $ in Thousands	Dec. 31, 2022 USD ($)
Debt Disclosure [Abstract]
2023	$ 3,321
2024	3,166
2025	3,181
2026	143,887
2027	$ 364

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Lessee, Lease, Description [Line Items]
Increase (decrease) in operating lease, right-of-use asset			$ (8.1)
Decrease in operating lease, liability, noncurrent			10.5
Decrease in operating lease, liability, current			0.6
Increase (decrease) in change between operating lease right-of-use assets and operating lease, liabilities			3
Loss on termination of lease			4.4
Impairment charge on termination of lease			2.9
COVID-19
Lessee, Lease, Description [Line Items]
Lessee, operating lease, deferred lease payments			0.5
Increase (decrease) in cash savings	$ (0.3)	$ (0.2)	$ 0.7
Minimum | Equipment
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	4 years
Operating lease, term of contract	2 years
Minimum | Manufacturing Facility
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	4 years
Maximum | Equipment
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	8 years
Operating lease, term of contract	5 years
Maximum | Manufacturing Facility
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	20 years

Leases - Finance and Operating

Leases - Finance and Operating Lease Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finance lease cost
Amortization of right-of-use assets	$ 1,318	$ 1,451	$ 1,272
Interest expense	351	213	192
Operating lease cost	8,285	8,015	8,397
Short-term lease cost	438	655	591
Sublease Income	(195)	0	0
Total lease cost	10,197	10,334	$ 10,452
Assets [Abstract]
Operating lease right-of-use assets	46,713	46,443
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	12,989	13,641
Lease, Right-Of-Use Asset	59,702	60,084
Liabilities, Current [Abstract]
Current portion of operating lease liabilities	5,294	5,704
Other current liabilities	2,610	3,111
Non-current liabilities:
Operating lease liabilities, net of current portion	51,411	51,295
Other non-current liabilities	3,828	5,446
Total lease liabilities	$ 63,143	$ 65,556

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in finance leases	$ 351	$ 213	$ 192
Operating cash flows used in operating leases	14,214	13,434	13,498
Financing cash flows used in finance leases	3,003	4,836	2,018
Right-of-use assets obtained in exchange for new finance lease liabilities	1,263	2,814	728
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 5,181	$ 0	$ 8,682

Leases - Weighted Average Remai

Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)	Dec. 31, 2022	Dec. 31, 2021
Weighted Average Remaining Lease Term
Finance Lease, Weighted Average Remaining Lease Term	3 years 1 month 6 days	3 years 3 months 18 days
Operating Lease, Weighted Average Remaining Lease Term	10 years 1 month 6 days	11 years 1 month 6 days
Weighted Average Discount Rate
Finance Lease, Weighted Average Discount Rate, Percent	5.30%	3%
Operating Lease, Weighted Average Discount Rate, Percent	7.50%	7%

Leases - Future Minimum Lease O

Leases - Future Minimum Lease Obligations (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Operating Leases
2023	$ 9,250
2024	8,419
2025	8,352
2026	8,193
2027	7,983
Thereafter	37,655
Total future minimum lease payments	79,852
Less: imputed interest	23,147
Operating Lease, Liability	56,705
Finance Lease, Liability, Payment, Due [Abstract]
2023	2,913
2024	1,819
2025	1,017
2026	950
2027	509
Thereafter	0
Total future minimum lease payments	7,208
Less: imputed interest	770
Finance Lease, Liability	$ 6,438

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands, shares in Millions		12 Months Ended
	Nov. 01, 2019	Dec. 31, 2022
Contingencies And Commitments [Line Items]
Shares issued (in shares)	14.4
Securities Offering Matter
Contingencies And Commitments [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 9,500
Litigation Settlement, Expense		1,000
Contract Claims
Contingencies And Commitments [Line Items]
Litigation Settlement, Amount Awarded to Other Party		1,800
Maximum
Contingencies And Commitments [Line Items]
Possible loss estimated		$ 5,000

Preferred Stock and Stockhold_3

Preferred Stock and Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
	Nov. 01, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of preferred stock		$ 0	$ 61,793	$ 0
Number of shares of common stock sold (in shares)	14,400
Series D Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued in transaction (in shares)			65
Temporary equity, par value (in dollars per share)		$ 0.01
Sale of stock, price per share (in dollars per share)		$ 1,000
Class of warrant or right, number of securities called by warrants or rights (in shares)		1,900
Class of warrant or right, exercise price of warrants or rights (in dollars per share)		$ 0.01
Temporary equity, liquidation price per share (in dollars per share)		$ 1,000
Temporary equity, dividend rate, percentage		10%
Preferred stock		$ 64,701	$ 53,807	0
Accrual of in-kind dividends		8,961	$ 6,222
Temporary Equity Dividends Unpaid Deemed		$ 18,000
Temporary Equity Dividend Rate Percentage Increase If No Dividend Paid		12%
Temporary Equity Dividend Rate Percentage Annual Increase		2.50%
Series B Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares)		1,500
Class of warrant or right, exercise price of warrants or rights (in dollars per share)		$ 12
Temporary equity, liquidation price per share (in dollars per share)			$ 1,000
Temporary equity, dividend rate, percentage		10.625%
Preferred stock			$ 0	105,086	$ 93,012
Accrual of in-kind dividends			14,008	$ 11,121
Temporary Equity Dividends Unpaid Deemed			$ 14,300

Preferred Stock and Stockhold_4

Preferred Stock and Stockholders' Equity - Change in Preferred Stock Carrying Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Increase (Decrease) in Temporary Equity [Roll Forward]
Gross proceeds from issuance of shares	$ 0	$ 61,793
Series D Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Beginning Balance	53,807	0
Relative fair value of Warrants issued	0	(14,839)
Recognition of bifurcated embedded derivative	0	(282)
Accrual of in-kind dividends	8,961	6,222
Amortization	1,933	913
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Ending Balance	64,701	53,807	$ 0
Series B Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Beginning Balance	$ 0	105,086	93,012
Accrual of in-kind dividends		14,008	11,121
Amortization		335	953
Temporary Equity, Redemption		119,429	0
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Ending Balance		$ 0	$ 105,086

Revenue from Contracts with C_3

Revenue from Contracts with Customers Summary of Sales to External Customer by Operating Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 498,738	$ 477,584	$ 427,534
Automotive Member
Disaggregation of Revenue [Line Items]
Net sales	238,231	220,873	201,811
General Industrial Member
Disaggregation of Revenue [Line Items]
Net sales	139,970	150,602	128,324
Electrical Member
Disaggregation of Revenue [Line Items]
Net sales	70,055	61,748	58,143
Other End Market Member
Disaggregation of Revenue [Line Items]
Net sales	50,482	44,361	39,256
United States
Disaggregation of Revenue [Line Items]
Net sales	301,823	293,235	268,551
CHINA
Disaggregation of Revenue [Line Items]
Net sales	51,556	56,972	52,005
BRAZIL
Disaggregation of Revenue [Line Items]
Net sales	48,216	35,455	27,744
Mexico
Disaggregation of Revenue [Line Items]
Net sales	40,645	35,697	29,865
GERMANY
Disaggregation of Revenue [Line Items]
Net sales	5,506	5,776	6,224
POLAND
Disaggregation of Revenue [Line Items]
Net sales	5,042	3,761	4,927
Other
Disaggregation of Revenue [Line Items]
Net sales	45,950	46,688	38,218
Operating Segments | Mobile Solutions
Disaggregation of Revenue [Line Items]
Net sales	293,536	285,863	256,360
Operating Segments | Mobile Solutions | Automotive Member
Disaggregation of Revenue [Line Items]
Net sales	197,341	182,094	170,389
Operating Segments | Mobile Solutions | General Industrial Member
Disaggregation of Revenue [Line Items]
Net sales	78,142	90,290	75,610
Operating Segments | Mobile Solutions | Electrical Member
Disaggregation of Revenue [Line Items]
Net sales	0	0	0
Operating Segments | Mobile Solutions | Other End Market Member
Disaggregation of Revenue [Line Items]
Net sales	18,053	13,479	10,361
Operating Segments | Mobile Solutions | United States
Disaggregation of Revenue [Line Items]
Net sales	140,931	140,383	129,147
Operating Segments | Mobile Solutions | CHINA
Disaggregation of Revenue [Line Items]
Net sales	46,045	52,227	46,442
Operating Segments | Mobile Solutions | BRAZIL
Disaggregation of Revenue [Line Items]
Net sales	47,266	34,644	27,055
Operating Segments | Mobile Solutions | Mexico
Disaggregation of Revenue [Line Items]
Net sales	23,348	19,520	16,465
Operating Segments | Mobile Solutions | GERMANY
Disaggregation of Revenue [Line Items]
Net sales	5,158	5,230	5,846
Operating Segments | Mobile Solutions | POLAND
Disaggregation of Revenue [Line Items]
Net sales	5,031	3,743	4,913
Operating Segments | Mobile Solutions | Other
Disaggregation of Revenue [Line Items]
Net sales	25,757	30,116	26,492
Operating Segments | Power Solutions
Disaggregation of Revenue [Line Items]
Net sales	205,204	191,800	171,269
Operating Segments | Power Solutions | Automotive Member
Disaggregation of Revenue [Line Items]
Net sales	40,890	38,779	31,422
Operating Segments | Power Solutions | General Industrial Member
Disaggregation of Revenue [Line Items]
Net sales	61,828	60,312	52,714
Operating Segments | Power Solutions | Electrical Member
Disaggregation of Revenue [Line Items]
Net sales	70,055	61,748	58,143
Operating Segments | Power Solutions | Other End Market Member
Disaggregation of Revenue [Line Items]
Net sales	32,431	30,961	28,990
Operating Segments | Power Solutions | United States
Disaggregation of Revenue [Line Items]
Net sales	160,894	152,931	139,499
Operating Segments | Power Solutions | CHINA
Disaggregation of Revenue [Line Items]
Net sales	5,511	4,745	5,563
Operating Segments | Power Solutions | BRAZIL
Disaggregation of Revenue [Line Items]
Net sales	950	811	689
Operating Segments | Power Solutions | Mexico
Disaggregation of Revenue [Line Items]
Net sales	17,297	16,177	13,400
Operating Segments | Power Solutions | GERMANY
Disaggregation of Revenue [Line Items]
Net sales	348	546	378
Operating Segments | Power Solutions | POLAND
Disaggregation of Revenue [Line Items]
Net sales	11	18	14
Operating Segments | Power Solutions | Other
Disaggregation of Revenue [Line Items]
Net sales	20,193	16,572	11,726
Intersegment Eliminations [Member]
Disaggregation of Revenue [Line Items]
Net sales	(2)	(79)	(95)
Intersegment Eliminations [Member] | Other End Market Member
Disaggregation of Revenue [Line Items]
Net sales	(2)	(79)	(95)
Intersegment Eliminations [Member] | United States
Disaggregation of Revenue [Line Items]
Net sales	$ (2)	$ (79)	$ (95)

Revenue from Contracts with C_4

Revenue from Contracts with Customers Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue, Major Customer [Line Items]
Net sales	$ 498,738	$ 477,584	$ 427,534

Revenue from Contracts with C_5

Revenue from Contracts with Customers Contract liabilities from contracts with customers (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Deferred revenue, beginning balance	$ 500
Deferred revenue, ending balance	700
Amounts included in deferred revenue for performance obligations satisfied or partially satisfied	$ 500

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 4,377	$ 3,216	$ 4,226
Unrecognized compensation costs related to unvested awards	$ 3,100
Unrecognized compensation costs, period for recognition	1 year 8 months 12 days
Term life of options	10 years
Number of options granted (in shares)			159,000
Weighted average grant date fair value of the options granted (in usd per share)			$ 4.76
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized	3,400,000
Discontinued Operations
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense			$ 800
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 3,635	$ 2,166	$ 3,393
Stock awards granted vesting period	3 years
Stock units issued (in shares)	897,000	459,000	460,000
Fair value assumptions, exercise price (in dollars per share)		$ 6.84	$ 9.35
Total grant-date fair value of restricted stock	$ 2,100	$ 2,800	$ 1,900
TSR Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units issued (in shares)	382,000
ROIC Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units issued (in shares)	408,000
Percentage of shares issuable based on threshold performance	50%		25%
Percentage of shares issuable based on target performance	100%
Percentage of shares issuable based on maximum performance	150%
Non-executive Directors | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted vesting period	1 year	1 year	1 year
Employees | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted vesting period	3 years	3 years	3 years

Share-Based Compensation - Comp

Share-Based Compensation - Components of Share-Based Compensation Expense by Type of Award (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ 4,377	$ 3,216	$ 4,226
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	3,635	2,166	3,393
Performance share units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	602	797	199
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ 140	$ 253	$ 634

Share-Based Compensation - Reco

Share-Based Compensation - Reconciliation of Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Beginning balance (in shares)	621,000
Granted (in shares)			159,000
Exercised (in shares)		(6,000)
Forfeited (in shares)	(4,000)
Expired (in shares)	(79,000)
Ending balance (in shares)	538,000	621,000
Exercisable (in shares)	515,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance (in usd per share)	$ 12.24
Forfeited (in usd per share)	9.44
Expired (in usd per Share)	9.71
Ending balance (in usd per share)	12.63	$ 12.24
Exercisable (in usd per share)	$ 12.77
Weighted-Average Remaining Contractual Term, Outstanding	3 years
Weighted- Average Remaining Contractual Term, Options exercisable	2 years 9 months 18 days
Aggregate Intrinsic Value, Outstanding	$ 0
Aggregate Intrinsic Value, Options exercisable	0
Share-based Payment Arrangement, Expense	$ (4,377)	$ (3,216)	$ (4,226)

Share-Based Compensation - Re_2

Share-Based Compensation - Reconciliation of Restricted Stock Option Activity (Detail) - Restricted Stock - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares)	469,000
Granted (in shares)	897,000	459,000	460,000
Vested (in shares)	(291,000)
Forfeited (in shares)	(37,000)
Ending balance (in shares)	1,038,000	469,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance (in usd per share)	$ 7.28
Granted (in usd per share)	3.31
Vested (in usd per share)	7.05
Forfeited (in usd per share)	3.93
Ending balance (in usd per share)	$ 4.03	$ 7.28

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of Performance Based Awards Goals with Respect to TSR and ROIC (Detail)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
TSR Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold performance, percentage	25%	35%	35%
Target Performance, percentage	55%	50%	50%
Maximum Performance, percentage	75%	75%	75%
ROIC Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold performance, percentage	6.40%	6.30%	6.70%
Percentage of shares issuable based on threshold performance	50%		25%
Target Performance, percentage	8.60%	7%	7.90%
Percentage of shares issuable based on target performance	100%
Maximum Performance, percentage	10%	8.60%	8.70%
Percentage of shares issuable based on maximum performance	150%

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Number of Awards Granted and Grand Date Fair Value (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
TSR Awards
Deferred Tax Assets Valuation Allowance [Line Items]
Number of shares (in shares)	382	142	139
Grant date fair value (in usd per share)	$ 2.53	$ 8.58	$ 10.88
ROIC Awards
Deferred Tax Assets Valuation Allowance [Line Items]
Number of shares (in shares)	408	172	157
Grant date fair value (in usd per share)	$ 2.62	$ 7.20	$ 9.44

Share-Based Compensation Share-

Share-Based Compensation Share-based Compensation - Summary of changes in unvested PSUs (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2022 $ / shares shares
TSR Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares) | shares	194
Granted (in shares) | shares	382
Expired (in shares) | shares	(84)
Ending balance (in shares) | shares	492
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance (in usd per share) | $ / shares	$ 9.59
Granted (in usd per share) | $ / shares	2.53
Expired (in usd per share) | $ / shares	10.88
Ending balance (in usd per share) | $ / shares	$ 3.87
ROIC Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares) | shares	228
Granted (in shares) | shares	408
Expired (in shares) | shares	(96)
Ending balance (in shares) | shares	540
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Beginning balance (in usd per share) | $ / shares	$ 8.14
Granted (in usd per share) | $ / shares	2.62
Expired (in usd per share) | $ / shares	9.44
Ending balance (in usd per share) | $ / shares	$ 3.74

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ (31,902)	$ (33,732)	$ (44,554)
Current-period other comprehensive income (loss) activity, tax	(60)	(898)	(1,978)
Other comprehensive income (loss)	(5,218)	1,830	10,822
Other comprehensive income (loss) before reclassifications, tax	(68)	(19)	3,764
Other comprehensive income (loss) before reclassifications, after tax	(4,798)	(1,076)	(14,126)
Amounts reclassified from AOCI, tax	8
Reclassification adjustment for discontinued operations	0	0	5,961
Amounts reclassified from AOCI, after tax	420
Ending balance	(37,120)	(31,902)	(33,732)
Foreign currency translation loss	(8,156)	(1,135)	(1,683)
Interest Expense
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Amounts reclassified from AOCI, tax		(18)	(2,068)
Amounts reclassified from AOCI, after tax		(55)	(6,838)
Loss on Interest Rate Swap
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Amounts reclassified from AOCI, tax		(861)	(3,674)
Amounts reclassified from AOCI, after tax		(2,851)	(12,149)
Accumulated other comprehensive income (loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Other comprehensive income (loss)	(5,218)	1,830	10,822
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(32,016)	(30,881)	(35,159)
Current-period other comprehensive income (loss) activity, before tax	(8,156)	(1,135)	4,278
Reclassification adjustment for discontinued operations			(5,961)
Ending balance	(40,172)	(32,016)	(30,881)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	151	(3,712)	(12,234)
Current-period other comprehensive income (loss) activity, before tax	2,998	3,863	8,522
Amounts reclassified from AOCI, before tax	(428)
Ending balance	3,149	151	(3,712)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	3,426	78	(16,207)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] | Interest Expense
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Amounts reclassified from AOCI, before tax		73	8,906
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] | Loss on Interest Rate Swap
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Amounts reclassified from AOCI, before tax		3,712	15,823
Income taxes
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(37)	861	2,839
Ending balance	$ (97)	$ (37)	$ 861

Net Income (Loss) Per Share Net

Net Income (Loss) Per Share Net Income (Loss) Per Share - Summary of Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Loss from continuing operations	$ (26,098)	$ (14,425)	$ (139,490)
Adjustment for preferred stock cumulative dividends and deemed dividends	(10,894)	(21,478)	(12,373)
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted	(36,992)	(35,903)	(151,863)
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	(36,992)	(35,903)	(151,863)
Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted	0	1,200	38,898
Numerator for basic loss from continuing operations per common share	(36,992)	(34,703)	(112,965)
Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic	0	1,200	38,898
Numerator for diluted loss from continuing operations per common share	(36,992)	(34,703)	(112,965)
Income from discontinued operations, net of tax (Note 2)	$ 0	$ 1,200	$ 38,898
Weighted average common shares outstanding (in shares)	43,738	42,991	42,692
Weighted Average Number of Shares, Restricted Stock	(951)	(461)	(493)
Weighted Average Number of Shares, Contingently Issuable	1,893	1,481	0
Basic loss from continuing operations per common share (in usd per share)	$ (0.83)	$ (0.82)	$ (3.60)
Basic income (loss) from discontinued operations per common share (in usd per share)	0	0.03	0.92
Basic net loss per common share (in usd per share)	(0.83)	(0.79)	(2.68)
Diluted loss from continuing operations per common share (in usd per share)	(0.83)	(0.82)	(3.60)
Diluted income (loss) from discontinued operations per common share (in usd per share)	0	0.03	0.92
Diluted net loss per common share (in usd per share)	(0.83)	(0.79)	(2.68)
Cash dividends declared per common share (in usd per share)	$ 0	$ 0	$ 0
Weighted average common shares outstanding (in shares)	44,680	44,011	42,199
Weighted average common shares outstanding (in shares)	44,680	44,011	42,199

Net Income (Loss) Per Share N_2

Net Income (Loss) Per Share Net Income (Loss) Per Share - Number of potentially dilutive share (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	2,057	2,266	21,392
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	557	766	871
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,500	1,500	1,500
Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	19,021

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2022 $ / shares
Net Income Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share minimum price range (in usd per share)	$ 7.93
Anti-dilutive securities excluded from computation of earnings per share maximum price range one (in usd per share)	$ 25.16

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants term	2 years 10 months 24 days	3 years 7 months 6 days
Payments for Hedge, Investing Activities	$ 0	$ 15,420	$ 4,133
Long-term Debt, Fair Value	155,200
Long-term Debt	157,104	$ 159,805
Debt, Long-Term and Short-Term, Combined Amount	$ 152,700
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock Change In Control Put Feature Probability Percentage	10%	10%
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock Change In Control Put Feature Probability Percentage	3%	1%
Series D Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrant or right, exercise price of warrants or rights (in dollars per share)	$ 0.01
Class of warrant or right, number of securities called by warrants or rights (in shares)	1,900
Temporary Equity Liquidation Preference Percentage	140%
Series B Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrant or right, exercise price of warrants or rights (in dollars per share)	$ 12
Class of warrant or right, number of securities called by warrants or rights (in shares)	1,500
Class Of Warrant Or Right Adjusted Exercise Price Of Warrants Or Rights	$ 11.49
Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
AOCI, cash flow hedge, cumulative gain (loss), net of tax	$ 3,100	$ 100
Interest Rate Swap | July 22 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	$ 60,000
Derivative, fixed interest rate	1.291%
Interest Rate Swap | February 8, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	$ 700,000
Derivative, fixed interest rate	2.4575%
Payments for Hedge, Investing Activities		$ 13,700

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Preferred Stock Derivative (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 2,959	$ 8,224	$ 3,117
Quoted Prices in Active Markets for Identical Assets (Level 1) | Derivative liability - other non-current liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	2,831	7,771
Significant Other Observable Inputs (Level 2) | Derivative liability - other non-current liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	0	0
Significant Unobservable Inputs (Level 3) | Derivative liability - other non-current liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	$ 128	$ 453

Fair Value Measurements - Prefe

Fair Value Measurements - Preferred Stock Derivative Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Beginning Balance	$ 8,224	$ 3,117
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances	0	15,121
Change in fair value	(5,265)	(7,009)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements	0	(3,005)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance	$ 2,959	$ 8,224

Fair Value Measurements - Effec

Fair Value Measurements - Effect of Interest Rate Swap (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Interest expense	$ 15,041	$ 12,664	$ 18,898
Derivative payments on interest rate swap	0	1,717	4,133
Loss on interest rate swap	0	2,033	11,669
Interest Rate Swap
Derivative [Line Items]
Interest expense	$ (428)	$ 73	$ 8,906

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative asset - other current assets	$ 0
Derivative asset - other non-current assets	0	$ 0
Derivative liability - other current liabilities		0
Total	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative asset - other current assets	2,130
Derivative asset - other non-current assets	1,023	284
Derivative liability - other current liabilities		(129)
Total	3,153	155
Significant Unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative asset - other current assets	0
Derivative asset - other non-current assets	0	0
Derivative liability - other current liabilities		0
Total	$ 0	$ 0